<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net" />
<link rel="shortcut icon" href="https://www.biorxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<meta name="type" content="article" />
<meta name="category" content="article" />
<meta name="HW.identifier" content="/biorxiv/early/2016/05/17/053967.atom" />
<meta name="HW.pisa" content="biorxiv;053967v1" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" />
<meta name="DC.Identifier" content="10.1101/053967" />
<meta name="DC.Date" content="2016-05-17" />
<meta name="DC.Publisher" content="Cold Spring Harbor Laboratory" />
<meta name="DC.Rights" content="© 2016, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/" />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested the hypothesis that increasing virus input titers in polyvalent inactivated HRV vaccine will result in broad nAb responses. Here, we show that serum nAb against many rhinovirus types can be induced by polyvalent, inactivated HRVs plus alhydrogel (alum) adjuvant. Using formulations up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related to sufficient quantity of input antigens, and valency was not a major factor for potency or breadth of the response. We for the first time generated a vaccine capable of inducing nAb responses to numerous and diverse HRV types." />
<meta name="DC.Contributor" content="Sujin Lee" />
<meta name="DC.Contributor" content="Minh Trang Nguyen" />
<meta name="DC.Contributor" content="Michael G. Currier" />
<meta name="DC.Contributor" content="Joe B. Jenkins" />
<meta name="DC.Contributor" content="Elizabeth A. Strobert" />
<meta name="DC.Contributor" content="Adriana E. Kajon" />
<meta name="DC.Contributor" content="Ranjna Madan-Lala" />
<meta name="DC.Contributor" content="Yury A. Bochkov" />
<meta name="DC.Contributor" content="James E. Gern" />
<meta name="DC.Contributor" content="Krishnendu Roy" />
<meta name="DC.Contributor" content="Xiaoyan Lu" />
<meta name="DC.Contributor" content="Dean D. Erdman" />
<meta name="DC.Contributor" content="Paul Spearman" />
<meta name="DC.Contributor" content="Martin L. Moore" />
<meta name="article:published_time" content="2016-05-17" />
<meta name="article:section" content="New Results" />
<meta name="citation_title" content="50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;Abstract&lt;/h3&gt;
&lt;p&gt;As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested the hypothesis that increasing virus input titers in polyvalent inactivated HRV vaccine will result in broad nAb responses. Here, we show that serum nAb against many rhinovirus types can be induced by polyvalent, inactivated HRVs plus alhydrogel (alum) adjuvant. Using formulations up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related to sufficient quantity of input antigens, and valency was not a major factor for potency or breadth of the response. We for the first time generated a vaccine capable of inducing nAb responses to numerous and diverse HRV types.&lt;/p&gt;" />
<meta name="citation_journal_title" content="bioRxiv" />
<meta name="citation_publisher" content="Cold Spring Harbor Laboratory" />
<meta name="citation_publication_date" content="2016/01/01" />
<meta name="citation_mjid" content="biorxiv;053967v1" />
<meta name="citation_id" content="053967v1" />
<meta name="citation_public_url" content="https://www.biorxiv.org/content/10.1101/053967v1" />
<meta name="citation_abstract_html_url" content="https://www.biorxiv.org/content/10.1101/053967v1.abstract" />
<meta name="citation_full_html_url" content="https://www.biorxiv.org/content/10.1101/053967v1.full" />
<meta name="citation_pdf_url" content="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967.full.pdf" />
<meta name="citation_doi" content="10.1101/053967" />
<meta name="citation_num_pages" content="23" />
<meta name="citation_article_type" content="Article" />
<meta name="citation_section" content="New Results" />
<meta name="citation_firstpage" content="053967" />
<meta name="citation_author" content="Sujin Lee" />
<meta name="citation_author_institution" content="Department of Pediatrics, Emory University, Atlanta, Georgia" />
<meta name="citation_author_institution" content="Children’s Healthcare of Atlanta, Atlanta" />
<meta name="citation_author" content="Minh Trang Nguyen" />
<meta name="citation_author_institution" content="Department of Pediatrics, Emory University, Atlanta, Georgia" />
<meta name="citation_author_institution" content="Children’s Healthcare of Atlanta, Atlanta" />
<meta name="citation_author" content="Michael G. Currier" />
<meta name="citation_author_institution" content="Department of Pediatrics, Emory University, Atlanta, Georgia" />
<meta name="citation_author_institution" content="Children’s Healthcare of Atlanta, Atlanta" />
<meta name="citation_author" content="Joe B. Jenkins" />
<meta name="citation_author_institution" content="Yerkes National Primate Research Center, Emory University, Atlanta" />
<meta name="citation_author" content="Elizabeth A. Strobert" />
<meta name="citation_author_institution" content="Yerkes National Primate Research Center, Emory University, Atlanta" />
<meta name="citation_author" content="Adriana E. Kajon" />
<meta name="citation_author_institution" content="Infectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque" />
<meta name="citation_author" content="Ranjna Madan-Lala" />
<meta name="citation_author_institution" content="The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta" />
<meta name="citation_author" content="Yury A. Bochkov" />
<meta name="citation_author_institution" content="Department of Pediatrics" />
<meta name="citation_author" content="James E. Gern" />
<meta name="citation_author_institution" content="Department of Pediatrics" />
<meta name="citation_author_institution" content="Department of Medicine, University of Wisconsin-Madison" />
<meta name="citation_author" content="Krishnendu Roy" />
<meta name="citation_author_institution" content="The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta" />
<meta name="citation_author" content="Xiaoyan Lu" />
<meta name="citation_author_institution" content="Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta" />
<meta name="citation_author" content="Dean D. Erdman" />
<meta name="citation_author_institution" content="Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta" />
<meta name="citation_author" content="Paul Spearman" />
<meta name="citation_author_institution" content="Department of Pediatrics, Emory University, Atlanta, Georgia" />
<meta name="citation_author_institution" content="Children’s Healthcare of Atlanta, Atlanta" />
<meta name="citation_author" content="Martin L. Moore" />
<meta name="citation_author_institution" content="Department of Pediatrics, Emory University, Atlanta, Georgia" />
<meta name="citation_author_institution" content="Children’s Healthcare of Atlanta, Atlanta" />
<meta name="citation_author_email" content="martin.moore@emory.edu" />
<meta name="citation_reference" content="Gwaltney, J. M., Jr., Hendley, J. O., Simon, G. &amp; Jordan, W. S., Jr. Rhinovirus infections in an industrial population. I. The occurrence of illness. N Engl J Med 275, 1261–1268, doi:10.1056/NEJM196612082752301 (1966)." />
<meta name="citation_reference" content="Glanville, N. &amp; Johnston, S. L. Challenges in developing a cross-serotype rhinovirus vaccine. Curr Opin Virol 11, 83–88, doi:10.1016/j.coviro.2015.03.004 (2015)." />
<meta name="citation_reference" content="Jain, S. et al. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med 373, 415–427, doi:10.1056/NEJMoa1500245 (2015)." />
<meta name="citation_reference" content="Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med 372, 835–845, doi:10.1056/NEJMoa1405870 (2015)." />
<meta name="citation_reference" content="Barclay, W. S., al-Nakib, W., Higgins, P. G. &amp; Tyrrell, D. A. The time course of the humoral immune response to rhinovirus infection. Epidemiol Infect 103, 659–669 (1989)." />
<meta name="citation_reference" content="Doggett, J. E., Bynoe, M. L. &amp; Tyrrell, D. A. Some attempts to produce an experimental vaccine with rhinoviruses. Br Med J 1, 34–36 (1963)." />
<meta name="citation_reference" content="Mufson, M. A. et al. Effect of Neutralizing Antibody on Experimental Rhinovirus Infection. Jama 186, 578–584 (1963)." />
<meta name="citation_reference" content="Perkins, J. C. et al. Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route. Am J Epidemiol 90, 319–326 (1969)." />
<meta name="citation_reference" content="Perkins, J. C. et al. Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness. Am J Epidemiol 90, 519–526 (1969)." />
<meta name="citation_reference" content="Buscho, R. F., Perkins, J. C., Knopf, H. L., Kapikian, A. Z. &amp; Chanock, R. M. Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine. J Immunol 108, 169–177 (1972)." />
<meta name="citation_reference" content="Mitchison, D. A. Prevention of Colds by Vaccination against a Rhinovirus: A Report by the Scientific Committee on Common Cold Vaccines. Br Med J 1, 1344–1349 (1965)." />
<meta name="citation_reference" content="Stott, E. J., Draper, C., Stons, P. B. &amp; Tyrrell, D. A. Absence of heterologous antibody responses in human volunteers after rhinovirus vaccination. (Brief report). Arch Gesamte Virusforsch 28, 89–92 (1969)." />
<meta name="citation_reference" content="Glanville, N. et al. Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein. PLoS Pathog 9, e1003669, doi:10.1371/journal.ppat.1003669 (2013)." />
<meta name="citation_reference" content="Cooney, M. K., Fox, J. P. &amp; Kenny, G. E. Antigenic groupings of 90 rhinovirus serotypes. Infect Immun 37, 642–647 (1982)." />
<meta name="citation_reference" content="McLean, G. R. et al. Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1. Antiviral Res 95, 193–201, doi:10.1016/j.antiviral.2012.06.006 (2012)." />
<meta name="citation_reference" content="Couch, R. B. The common cold: control? J Infect Dis 150, 167–173 (1984)." />
<meta name="citation_reference" content="Fox, J. P. Is a rhinovirus vaccine possible? Am J Epidemiol 103, 345–354 (1976)." />
<meta name="citation_reference" content="Crowe, J. E., Jr. Universal flu vaccines: primum non nocere. Sci Transl Med 5, 200fs234, doi:10.1126/scitranslmed.3007118 (2013)." />
<meta name="citation_reference" content="Vollmers, C., Sit, R. V., Weinstein, J. A., Dekker, C. L. &amp; Quake, S. R. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proc Natl Acad Sci U S A 110, 13463–13468, doi:10.1073/pnas.1312146110 (2013)." />
<meta name="citation_reference" content="McIntyre, C. L., Knowles, N. J. &amp; Simmonds, P. Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types. J Gen Virol 94, 1791–1806, doi:10.1099/vir.0.053686-0 (2013)." />
<meta name="citation_reference" content="Palmenberg, A. C. et al. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 324, 55–59, doi:10.1126/science.1165557 (2009)." />
<meta name="citation_reference" content="Lee, W. M. et al. Human rhinovirus species and season of infection determine illness severity. Am J Respir Crit Care Med 186, 886–891, doi:10.1164/rccm.201202-0330OC (2012)." />
<meta name="citation_reference" content="Miller, E. K. etal. A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol 123, 98–104e101, doi:S0091-6749(08)01847-2 [pii]10.1016/j.jaci.2008.10.007 (2009)." />
<meta name="citation_reference" content="Arden, K. E., McErlean, P., Nissen, M. D., Sloots, T. P. &amp; Mackay, I. M. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J Med Virol 78, 1232–1240, doi:10.1002/jmv.20689 (2006)." />
<meta name="citation_reference" content="Kistler, A. et al. Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity. J Infect Dis 196, 817–825, doi:10.1086/520816 (2007)." />
<meta name="citation_reference" content="Lamson, D. etal. MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis 194, 1398–1402, doi:10.1086/508551 (2006)." />
<meta name="citation_reference" content="Renwick, N. et al. A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany. J Infect Dis 196, 1754–1760, doi:10.1086/524312 (2007)." />
<meta name="citation_reference" content="Bochkov, Y. A. et al. Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C. Nat Med 17, 627–632, doi:10.1038/nm.2358 (2011)." />
<meta name="citation_reference" content="Bochkov, Y. A. et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A 112, 5485–5490, doi:10.1073/pnas.1421178112 (2015)." />
<meta name="citation_reference" content="Bartlett, N. W. et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nature medicine 14, 199–204, doi:10.1038/nm1713 (2008)." />
<meta name="citation_reference" content="Blanco, J. C. et al. Prophylactic Antibody Treatment and Intramuscular Immunization Reduce Infectious Human Rhinovirus 16 Load in the Lower Respiratory Tract of Challenged Cotton Rats. Trials Vaccinol 3, 52–60, doi:10.1016/j.trivac.2014.02.003 (2014)." />
<meta name="citation_reference" content="Kim, J. H., Davis, W. G., Sambhara, S. &amp; Jacob, J. Strategies to alleviate original antigenic sin responses to influenza viruses. Proc Natl Acad Sci U S A 109, 13751–13756, doi:10.1073/pnas.0912458109 (2012)." />
<meta name="citation_reference" content="Hamory, B. H., Hamparian, V. V., Conant, R. M. &amp; Gwaltney, J. M., Jr. Human responses to two decavalent rhinovirus vaccines. J Infect Dis 132, 623–629 (1975)." />
<meta name="citation_reference" content="Racaniello, V. R. &amp; Baltimore, D. Cloned poliovirus complementary DNA is infectious in mammalian cells. Science 214, 916–919 (1981)." />
<meta name="citation_reference" content="Farid, S. S., Washbrook, J. &amp; Titchener-Hooker, N. J. Decision-support tool for assessing biomanufacturing strategies under uncertainty: stainless steel versus disposable equipment for clinical trial material preparation. Biotechnol Prog 21, 486–497, doi:10.1021/bp049692b (2005)." />
<meta name="citation_reference" content="Thomassen, Y. E. et al. Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals. PLoS One 8, e83374, doi:10.1371/journal.pone.0083374 (2013)." />
<meta name="citation_reference" content="Thomassen, Y. E. et al. Scale-down of the inactivated polio vaccine production process. BiotechnolBioeng 110, 1354–1365, doi:10.1002/bit.24798 (2013)." />
<meta name="citation_reference" content="Reed, L. J. &amp; Muench, H. A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493–497 (1938)." />
<meta name="citation_reference" content="Kattur Venkatachalam, A. R., Szyporta, M., Kiener, T. K., Balraj, P. &amp; Kwang, J. Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column. Virol J 11, 99, doi:10.1186/1743-422X-11-99 (2014)." />
<meta name="citation_reference" content="Weiss, V. U. et al. Capillary electrophoresis, gas-phase electrophoretic mobility molecular analysis, and electron microscopy: effective tools for quality assessment and basic rhinovirus research. Methods MolBiol 1221, 101–128, doi:10.1007/978-1-4939-1571-2_9 (2015)." />
<meta name="twitter:title" content="50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" />
<meta name="twitter:site" content="@biorxivpreprint" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="twitter:description" content="As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested the hypothesis that increasing virus input titers in polyvalent inactivated HRV vaccine will result in broad nAb responses. Here, we show that serum nAb against many rhinovirus types can be induced by polyvalent, inactivated HRVs plus alhydrogel (alum) adjuvant. Using formulations up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related to sufficient quantity of input antigens, and valency was not a major factor for potency or breadth of the response. We for the first time generated a vaccine capable of inducing nAb responses to numerous and diverse HRV types." />
<meta name="og-title" property="og:title" content="50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques" />
<meta name="og-url" property="og:url" content="https://www.biorxiv.org/content/10.1101/053967v1" />
<meta name="og-site-name" property="og:site_name" content="bioRxiv" />
<meta name="og-description" property="og:description" content="As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested the hypothesis that increasing virus input titers in polyvalent inactivated HRV vaccine will result in broad nAb responses. Here, we show that serum nAb against many rhinovirus types can be induced by polyvalent, inactivated HRVs plus alhydrogel (alum) adjuvant. Using formulations up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related to sufficient quantity of input antigens, and valency was not a major factor for potency or breadth of the response. We for the first time generated a vaccine capable of inducing nAb responses to numerous and diverse HRV types." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://www.biorxiv.org/sites/default/files/images/biorxiv_logo_homepage7-5-small.png" />
<meta name="citation_date" content="2016-05-17" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/053967v1.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/053967v1.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/053967v1.ppt" />
<meta name="description" content="bioRxiv - the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution" />
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
<link rel="canonical" href="https://www.biorxiv.org/content/10.1101/053967v1" />
<link rel="shortlink" href="https://www.biorxiv.org/node/14772" />
    <title>50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques | bioRxiv</title>  
    <link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__jMRAK66KMC1e4TQlwUNn3KiWVDC5AjueUAYEm1xBY_U__KSUjdT4jdcJ4qJz6fKY1K9WkYh1a5EcaWZxt_-zbTis__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?q8qadd" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__qlYh2rDEXmsOlJKnxoaEiN2PoZU7YzDXSSTk6K1VAQE__XkaAZGAgxyDmOmv0mrGL0sA-jzEgAbgA12amvVPlIf0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__vup9YXfxWOBOGbthJCUtxdPS6xRY2OQ_vXqbojfxPAk__ziC21uj-cnpEf3LG0kjRMEQHSEtjX5ljVuosklz2DZ4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__B6tGdsQSt1vT8d8j-19-oS4FKJe83RrSNBkjPs9jfos__6VkE5WcQmmQpSVTQx-xS2-zn_nlwFlDm-EN1HLJNjrA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__78WRxe8YsWkYp6RcQ_VwTjFG__x9mi_NTPqoxAwFUsA__F3sVKlGyHKCaAPI_WdiHD7l_-05B6b9bLdUwzi1me90__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://www.biorxiv.org/sites/default/files/advagg_css/css__dAeSAHswzRXxn-2n4D6zNPmcZDmwaqqLzE-2ab_8jKw__f_9pwrTE8mmshoJRfurwkQ36QonD_Jiwbop2sscnkrE__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/all/libraries/modernizr/modernizr.min.js?q8qadd"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__yOhrJUBmMpN-jsuQlJYmS8ovkQU6I6KInr295HrSTb0__c--zHhbuOWmkdWkJYXiNWDmkpDRPesmbBjGlQcyqBOY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js___KyvuEvfmewWxdOLBXTYsSUo8Pfm_DijV6fWtGvSL_k__HSKkTgIr7nDcdvQYewipf6v4ak6ZLUOQkwPj44wKouA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__OGPr3wJNGw2BAY3Tj6TjIBwKmjQh5i-7muOaPrr0MFA__fCWiU_pDm6xztXUSccH7zrf5422-kgOkuLdWyafrH_0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__hqoKSXYZqkcZkXP--ltzsy0Y3txW5TJBw6HT1khr30Y__6_HqNYoBVMxlkWZwdscqCLCtCxpOhl9_rIOpTDdaI0k__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__lrItkPGmrIuH-E_sdUWEK2i9eTqLar16BAHVxNTWqrc__FhtnljBrjuzYWWrT_f4OYV4jtMBituhMpusb3h0m0rY__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-45638026-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__1PtAOZ8x7l6QAi8D7X6Kj_Y7HcUOFzvWRvvYHUcCT98__U8IB92u_CnnGwJ-X_xaUa9lzsC8OzUfN0WkK2JQfirg__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"B3k7WZEYRH8T6rCIcF2jNC-yNhGdoXLkP01eWMpwO-0","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"modules\/comment\/comment.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"modules\/node\/node.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"modules\/forum\/forum.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"sites\/default\/modules\/biorxiv\/css\/biorxiv.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_collection\/css\/highwire_subject_collection.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire.highwire-list-expand.css":1,"public:\/\/ctools\/css\/bab59090150caf0c64e27afa1b36eef1.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"0":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/default\/modules\/jnl_biorxiv_styles\/css\/biorxiv-styles.css.less":1,"https:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"http:\/\/d33xdlntwy0kbs.cloudfront.net\/cshl_custom.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/adv-search-collection-toggle.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/default\/modules\/jnl_biorxiv_styles\/js\/biorxiv-scripts.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/default\/modules\/contrib\/disqus\/disqus.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/twitter_button.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/facebook_like.js":1,"sites\/all\/modules\/contrib\/service_links\/js\/google_plus_one.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.highwire-list-expand.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"14772","apath":"\/biorxiv\/early\/2016\/05\/17\/053967.atom","pisa":"biorxiv;053967v1","markup":[{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;053967\/DC1"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;053967\/DC1"},{"requested":"full-text","variant":"full-text","view":"full","pisa":"biorxiv;053967v1"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;053967\/DC1"},{"requested":"index","variant":"index","view":"full","pisa":"biorxiv;053967\/DC1"}],"processed":["highwire_math"],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"biorxivstage","url":"https:\/\/www.biorxiv.org\/content\/10.1101\/053967v1","title":"50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques","identifier":"node\/14772"},"panels_ajax_pane":{"new-41":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022pxGt8XTY5oxf5zgJ0cP2U\\\\\\\/nJUraPJdgfhTMo+kuxyQvpMPVkd8vdlmQRfMduwJoLoVhuCFfia7aX9Yv6kAZFSRi4YibZRA4XjvWIadcAGaUwYDWqhU8FMXWBoTvURpEZEvecpdvdUYUlyD3vCkHKc6Ih6a9Vn2v9yXd2na20aqCbQwa+17VaOCLmTKWqX3kF3f+2quNmGVVy3KVJXxQkGXJa7DBaTSja0PBfwEU1ikMyanm2pwOznZf4aD04y8k1FWHEgPk0Vku+yJAQaIUiqp9in\\\\\\\/s3fzILFB9CrBnqxe4WysnarzvcOai\\\\\\\/1Urbfp8TMPtz0Tn9524JOH+XXgVh6u+IMVj6VgtGu\\\\\\\/kX3asCkOyrW8W1KYN8EjL\\\\\\\/cuNopzS9Im6scEpuOmMg+xO\\\\\\\/STO+NMiuxGiVHcrx72OK8XZhYxN9HNwDzfNMYFlwVb2o7w6q4kZUQxSqtKcKjnd+fem8LpEHI7uwnkI6ZtA7fuVVX7fY1EWzwr0KdHFBHUV8J\\\\\\\/UTY6liPCuJ1BK5n+gnhjXnV5OPVh4J1tCcob0m\\\\\\\/ettlrwCkG+BUgg8\\\\\\\/RcRB++HiDXdD9eDOgizN2gBDUTYhOCfgPrBOivA\\\\\\\/vWN\\\\\\\/7\\\\\\\/Upx1XKhjcXiXa2nshVU6i6cxCcDUwBDzycW00uVHgCNJERLJUr1LjVustlrIYZ2rS9+rOkor50sHxdeBUUeVmwsZ5JniILGbYwphAsWdg43O+pUPRTZRy2DJzLiE8C0L32lujYbrXXJa7EJefjSfFdnDrgeO7mkmwamEgev\\\\\\\/GEmN8DeC+BNn4sw+650yqqL0uLi\\\\\\\/vCrbJ4\\\\\\\/MO74jfdkhZV7F2QGO30zxG5gCWhf9PCBHOmeXBaqkVfgyBDclHFUTqvb2GatGKh6CBEA3HvjDGWoZdSeVXzHlUcfz+zWp2OqCAOruZzUxnFMeQtbNo+ogLY9417B7FMdRKVkjwLbc43A1J42B0r9lrBAL+nVTPfxPFvCgAHGxWX6jnrjOs69SA9iq3t\\\\\\\/PA5qDiJqeWL0BBneM+G4xUEImlQXNFz3o2Mo7Pces7vtP64bdyPaiplI\\\\\\\/1iOZlDD919wNDnXjAEmkxzgzgZN+mCI+Rd0KoGvNrXAq4KsYQi3jFWc7bG5MWpHSwWQf6LckGzki3TwmWeXG6QlHx3AIApF5nT3EznPX7zljqyoI4V9VMpWnlhlpk8W16Ul4DtWeLTh48M3IGpf3Oq418BcsNGzW3VsD04ZZ\\\\\\\/23hypkCp+5IDTAUl0ImkIihgH6ofn+pgc7\\\\\\\/ZRTrlfCENztVFKOK2o\\\\\\\/gTKDXEku1r8CJ2WE20l2jh9220oX23L5WKBtfkd3A=\\\u0022,\\\u0022iv\\\u0022:\\\u0022UrKWfCxjZHvld8mQoZZhlQ==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022ac1b5100919f8b212d7f02650533c26c8cbfb1e9677e517ec312d55741a0ad56\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/053967v1.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.biorxiv.org\/sites\/default\/files\/bioRxiv_article.jpg"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"biorxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-14772 node-type-highwire-article context-content hw-default-jcode-biorxiv hw-article-type-article hw-article-category-new-results">
<!-- Google Tag Manager -->
<noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-M677548" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script type="text/javascript">(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-M677548');</script>
<!-- End Google Tag Manager -->
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
        <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
    
  <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
    <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="branding-data clearfix">
            <div class="logo-img">
        <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0"><img alt="bioRxiv" src="https://www.biorxiv.org/sites/default/files/bioRxiv_article.jpg" /></a>      </div>
                </div>
          </div>
</div><div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">Home</a></li>
<li class="leaf" role="menuitem"><a href="/about-biorxiv" class="" data-icon-position="" data-hide-link-title="0">About</a></li>
<li class="leaf" role="menuitem"><a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">Submit</a></li>
<li class="last leaf" role="menuitem"><a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">ALERTS / RSS</a></li>
</ul></nav>    </div>
  </div>
</div><div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/053967v1.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search" type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--2" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-VpRCmMZtqZPk3V7lLlZRy-GRMle6F-6-oXIEVORruZg" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 advanced-search-link" >
  
      
  
  <div class="pane-content">
    <a href="/search">Advanced Search</a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="14772" id="node14772" data-pisa="biorxiv;053967v1" data-pisa-master="biorxiv;053967" data-apath="/biorxiv/early/2016/05/17/053967.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-top clearfix has-author-tooltip" >

      <span class="biorxiv-article-type">
        New Results    </span>
  
        <h1 class="highwire-cite-title" id="page-title">50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques</h1>  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Sujin</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Minh Trang</span> <span class="nlm-surname">Nguyen</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Michael G.</span> <span class="nlm-surname">Currier</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Joe B.</span> <span class="nlm-surname">Jenkins</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Elizabeth A.</span> <span class="nlm-surname">Strobert</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Adriana E.</span> <span class="nlm-surname">Kajon</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ranjna</span> <span class="nlm-surname">Madan-Lala</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yury A.</span> <span class="nlm-surname">Bochkov</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">James E.</span> <span class="nlm-surname">Gern</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Krishnendu</span> <span class="nlm-surname">Roy</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Xiaoyan</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="11"><span class="nlm-given-names">Dean D.</span> <span class="nlm-surname">Erdman</span></span>, <span class="highwire-citation-author" data-delta="12"><span class="nlm-given-names">Paul</span> <span class="nlm-surname">Spearman</span></span>, <span class="highwire-citation-author" data-delta="13"><span class="nlm-given-names">Martin L.</span> <span class="nlm-surname">Moore</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">doi:</span> https://doi.org/10.1101/053967 </span></div>
  
  
  </div>
<div id="hw-article-author-popups-node14772" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Sujin Lee </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Pediatrics, Emory University, Atlanta, Georgia</span> 30322, <span class='nlm-country'>USA</span>.</div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Children’s Healthcare of Atlanta, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Sujin%2BLee%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Lee%20S&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ASujin%2BLee%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">Minh Trang Nguyen </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Pediatrics, Emory University, Atlanta, Georgia</span> 30322, <span class='nlm-country'>USA</span>.</div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Children’s Healthcare of Atlanta, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Minh%2BTrang%2BNguyen%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Nguyen%20MT&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AMinh%2BTrang%2BNguyen%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Michael G. Currier </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Pediatrics, Emory University, Atlanta, Georgia</span> 30322, <span class='nlm-country'>USA</span>.</div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Children’s Healthcare of Atlanta, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Michael%2BG.%2BCurrier%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Currier%20MG&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AMichael%2BG.%2BCurrier%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Joe B. Jenkins </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Yerkes National Primate Research Center, Emory University, Atlanta</span>, GA 30329.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Joe%2BB.%2BJenkins%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Jenkins%20JB&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJoe%2BB.%2BJenkins%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-4"><div class="author-tooltip-name">Elizabeth A. Strobert </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>3</span><span class='nlm-institution'>Yerkes National Primate Research Center, Emory University, Atlanta</span>, GA 30329.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Elizabeth%2BA.%2BStrobert%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Strobert%20EA&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AElizabeth%2BA.%2BStrobert%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-5"><div class="author-tooltip-name">Adriana E. Kajon </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>4</span><span class='nlm-institution'>Infectious Disease Program, Lovelace Respiratory Research Institute, Albuquerque</span>, New Mexico 87108, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Adriana%2BE.%2BKajon%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Kajon%20AE&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AAdriana%2BE.%2BKajon%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-6"><div class="author-tooltip-name">Ranjna Madan-Lala </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>5</span><span class='nlm-institution'>The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Ranjna%2BMadan-Lala%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Madan-Lala%20R&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ARanjna%2BMadan-Lala%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-7"><div class="author-tooltip-name">Yury A. Bochkov </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>6</span><span class='nlm-institution'>Department of Pediatrics</span></div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Yury%2BA.%2BBochkov%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Bochkov%20YA&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AYury%2BA.%2BBochkov%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-8"><div class="author-tooltip-name">James E. Gern </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>6</span><span class='nlm-institution'>Department of Pediatrics</span></div><div class='author-affiliation'><span class='nlm-sup'>7</span><span class='nlm-institution'>Department of Medicine, University of Wisconsin-Madison</span>, Madison, Wisconsin 53792, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=James%2BE.%2BGern%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Gern%20JE&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJames%2BE.%2BGern%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-9"><div class="author-tooltip-name">Krishnendu Roy </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>5</span><span class='nlm-institution'>The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Krishnendu%2BRoy%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Roy%20K&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AKrishnendu%2BRoy%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-10"><div class="author-tooltip-name">Xiaoyan Lu </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>8</span><span class='nlm-institution'>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta</span>, Georgia 30333, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Xiaoyan%2BLu%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Lu%20X&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AXiaoyan%2BLu%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-11"><div class="author-tooltip-name">Dean D. Erdman </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>8</span><span class='nlm-institution'>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta</span>, Georgia 30333, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Dean%2BD.%2BErdman%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Erdman%20DD&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3ADean%2BD.%2BErdman%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-12"><div class="author-tooltip-name">Paul Spearman </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Pediatrics, Emory University, Atlanta, Georgia</span> 30322, <span class='nlm-country'>USA</span>.</div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Children’s Healthcare of Atlanta, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Paul%2BSpearman%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Spearman%20P&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3APaul%2BSpearman%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-13"><div class="author-tooltip-name">Martin L. Moore </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'><span class='nlm-sup'>1</span><span class='nlm-institution'>Department of Pediatrics, Emory University, Atlanta, Georgia</span> 30322, <span class='nlm-country'>USA</span>.</div><div class='author-affiliation'><span class='nlm-sup'>2</span><span class='nlm-institution'>Children’s Healthcare of Atlanta, Atlanta</span>, Georgia 30322, <span class='nlm-country'>USA</span>.</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Martin%2BL.%2BMoore%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Moore%20ML&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3AMartin%2BL.%2BMoore%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:martin.moore@emory.edu" class="" data-icon-position="" data-hide-link-title="0">martin.moore@emory.edu</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/10.1101/053967v1" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="" data-url-enabled="1">Abstract</a><a href="/panels_ajax_tab/biorxiv_tab_art/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/053967v1.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="full-text" data-url-enabled="1">Full Text</a><a href="/panels_ajax_tab/article_tab_full_text/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/053967v1.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="article-info" data-url-enabled="1">Info/History</a><a href="/panels_ajax_tab/biorxiv_tab_info/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/053967v1.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="article-metrics" data-url-enabled="1">Metrics</a><a href="/panels_ajax_tab/article_tab_metrics/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/10.1101/053967v1.supplementary-material" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="supplementary-material" data-url-enabled="1">Supplementary material</a><a href="/panels_ajax_tab/biorxiv_tab_data/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/10.1101/053967v1.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:14772" data-trigger="full.pdf+html" data-url-enabled="1"><i class="icon-file-alt"></i> Preview PDF</a><a href="/panels_ajax_tab/biorxiv_tab_pdf/node:14772/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-article_tab_full_text"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">Abstract</h2><p id="p-3">As the predominant etiological agent of the common cold, human rhinovirus (HRV) is the leading cause of human infectious disease. Early studies showed monovalent formalin-inactivated HRV vaccine can be protective, and virus-neutralizing antibodies (nAb) correlated with protection. However, co-circulation of many HRV types discouraged further vaccine efforts. We approached this problem straightforwardly. We tested the hypothesis that increasing virus input titers in polyvalent inactivated HRV vaccine will result in broad nAb responses. Here, we show that serum nAb against many rhinovirus types can be induced by polyvalent, inactivated HRVs plus alhydrogel (alum) adjuvant. Using formulations up to 25-valent in mice and 50-valent in rhesus macaques, HRV vaccine immunogenicity was related to sufficient quantity of input antigens, and valency was not a major factor for potency or breadth of the response. We for the first time generated a vaccine capable of inducing nAb responses to numerous and diverse HRV types.</p></div><div class="section" id="sec-1"><h2 class="">Introduction</h2><p id="p-4">HRV causes respiratory illness in billions of people annually, a socioeconomic burden<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1"><sup>1</sup></a>. HRV also causes pneumonia hospitalizations in children and adults and exacerbations of asthma and chronic obstructive pulmonary disease (COPD)<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2"><sup>2</sup></a>. HRV was found to be the second leading cause of community-acquired pneumonia requiring hospitalization in US children, second only to respiratory syncytial virus, and the most common pathogen associated with pneumonia hospitalization in US adults<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3"><sup>3</sup></a>,<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4"><sup>4</sup></a>. A vaccine for HRV could alleviate serious disease in asthma and COPD, reduce pneumonia hospitalizations, and have widespread benefits for society on the whole. Decades ago, researchers identified inactivated HRV as a protective vaccine, defined virus-neutralizing antibodies (nAb) as a correlate of protection, and estimated duration of immunity<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5"><sup>5</sup></a><sup>−</sup><a id="xref-ref-11-1" class="xref-bibr" href="#ref-11"><sup>11</sup></a>. Trials with monovalent HRV vaccine demonstrated that protection from homologous challenge and disease can be achieved with formalin-inactivated virus given intramuscularly (i.m.) or intranasally (i.n.) <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8"><sup>8</sup></a>,<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10"><sup>10</sup></a>,<a id="xref-ref-11-2" class="xref-bibr" href="#ref-11"><sup>11</sup></a>. Humoral immunity to heterologous virus types was not observed, though cross-reactive CD8 T cells can promote clearance<a id="xref-ref-12-1" class="xref-bibr" href="#ref-12"><sup>12</sup></a>,<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13"><sup>13</sup></a>. Limited cross-neutralizing Abs can be induced by hyper-immunization in animals<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14"><sup>14</sup></a>,<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15"><sup>15</sup></a>. The possibility of a vaccine composed of 50, 100, or more distinct HRV antigens has been viewed as formidable or impossible<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2"><sup>2</sup></a>,<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16"><sup>16</sup></a>,<a id="xref-ref-17-1" class="xref-bibr" href="#ref-17"><sup>17</sup></a>. There are two main challenges, generating a broad immune response and the feasibility of composing such a vaccine. The Ab repertoire is theoretically immense, and most vaccines in clinical use are thought to work via a polyclonal Ab response. Deep-sequencing of human Ab genes following vaccination against influenza virus found thousands of Ab lineages<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18"><sup>18</sup></a>,<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19"><sup>19</sup></a>. Whole pathogen and polyvalent vaccines carrying natural immunogens take advantage of this capacity. Valency has increased for pneumococcal and human papillomavirus virus vaccines in recent years. Given the significance of HRV, we tested polyvalent HRV vaccines.</p><p id="p-5">There are three species of HRV, A, B, and C. Sequencing methods define 83 A types, 32 B types, and 55 C types<a id="xref-ref-20-1" class="xref-bibr" href="#ref-20"><sup>20</sup></a>,<a id="xref-ref-21-1" class="xref-bibr" href="#ref-21"><sup>21</sup></a>. It is thought there are 150 to 170 serologically distinct HRV types. HRV A and C are associated with asthma exacerbations and with more acute disease than HRV B<a id="xref-ref-22-1" class="xref-bibr" href="#ref-22"><sup>22</sup></a>,<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23"><sup>23</sup></a>. HRV C was discovered in 2006 and 2007<a id="xref-ref-24-1" class="xref-bibr" href="#ref-24"><sup>24</sup></a><sup>−</sup><a id="xref-ref-27-1" class="xref-bibr" href="#ref-27"><sup>27</sup></a> and recently cultured in cells<a id="xref-ref-28-1" class="xref-bibr" href="#ref-28"><sup>28</sup></a>,<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29"><sup>29</sup></a>. Here, we focused on HRV A, the most prevalent species. There are no permissive animal challenge models of HRV virus replication, but mice and cotton rats can recapitulate aspects of HRV pathogenesis<a id="xref-ref-30-1" class="xref-bibr" href="#ref-30"><sup>30</sup></a>,<a id="xref-ref-31-1" class="xref-bibr" href="#ref-31"><sup>31</sup></a>. The best efficacy model is human challenge. In monovalent vaccine trials, formalin-inactivated HRV-13 was validated prior to clinical testing by assessing induction of nAb in guinea pigs, and a reciprocal serum nAb titer of 2<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3"><sup>3</sup></a> resulting from four doses of a 1:125 dilution of the vaccine correlated with vaccine efficacy in humans<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9"><sup>9</sup></a>. Although the nAb titer required for protection is not defined, early studies established inactivated HRV as protective in humans, and immunogenicity in animals informed clinical testing.</p></div><div class="section" id="sec-2"><h2 class="">Results and discussion</h2><p id="p-6">We first used BALB/c mice to test immunogenicity. We propagated HRVs in H1-HeLa cells and inactivated infectivity using formalin. Sera from naïve mice had no detectable nAb against HRV-16 (<a id="xref-fig-1-1" class="xref-fig" href="#F1"><strong>Fig. 1</strong></a>). Alum adjuvant enhanced the nAb response induced by i.m. inactivated HRV-16 (<a id="xref-fig-1-2" class="xref-fig" href="#F1"><strong>Fig. 1</strong></a>). There was no effect of valency (comparing 1-, 3-, 5-, 7-, and 10-valent) on the nAb response induced by inactivated HRV-16 or to the 3 types in the 3-valent vaccine (HRV-16, HRV-36, and HRV-78) (<a id="xref-fig-1-3" class="xref-fig" href="#F1"><strong>Fig. 1</strong></a>). The 50% tissue culture infectious dose (TCID<sub>50</sub>) titers of the input viruses prior to inactivation (inactivated-TCID<sub>50</sub>) are provided in <strong>Supplemental Table 1</strong>. Original antigenic sin can occur when sequential exposure to related virus variants results in biased immunity to the type encountered first<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32"><sup>32</sup></a>. In bivalent HRV-immune mice, we observed modest original antigenic sin following prime vaccination with 10-valent inactivated HRV, and boost vaccination partially alleviated the effect (<strong>Supplemental Fig. 1</strong>), similar to influenza virus<a id="xref-ref-32-2" class="xref-bibr" href="#ref-32"><sup>32</sup></a>. Collectively, these results prompted us to explore more fully the nAb response to polyvalent HRV vaccine.</p><div id="F1" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Immunogenicity of inactivated HRV is not affected by increasing valency from one to ten. Mice were vaccinated i.m. with 1-valent inactivated HRV-16 with or without alum adjuvant (5 mice per group) or with 3-valent, 5-valent, 7-valent, or 10-valent inactivated HRV with alum (20 mice per group). HRV types and inactivated-TCID50 doses are specified in Supplemental Table 1. Sera were collected 18 days after vaccination and pooled for each group. Serum nAb titers were measured against HRV-16, HRV-36, and HRV-78. The dashed line represents limit of detection (LOD). Error bars show 95% confidence interval. Data depict three independent experiments combined." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1581022710" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Immunogenicity of inactivated HRV is not affected by increasing valency from one to ten.&lt;/span&gt; Mice were vaccinated i.m. with 1-valent inactivated HRV-16 with or without alum adjuvant (5 mice per group) or with 3-valent, 5-valent, 7-valent, or 10-valent inactivated HRV with alum (20 mice per group). HRV types and inactivated-TCID&lt;sub&gt;50&lt;/sub&gt; doses are specified in &lt;strong&gt;Supplemental Table 1&lt;/strong&gt;. Sera were collected 18 days after vaccination and pooled for each group. Serum nAb titers were measured against HRV-16, HRV-36, and HRV-78. The dashed line represents limit of detection (LOD). Error bars show 95% confidence interval. Data depict three independent experiments combined.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F1.medium.gif" width="440" height="161"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 1." src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F1.medium.gif" width="440" height="161"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">Figure 1.</span> <span class="caption-title">Immunogenicity of inactivated HRV is not affected by increasing valency from one to ten.</span><p id="p-7" class="first-child">Mice were vaccinated i.m. with 1-valent inactivated HRV-16 with or without alum adjuvant (5 mice per group) or with 3-valent, 5-valent, 7-valent, or 10-valent inactivated HRV with alum (20 mice per group). HRV types and inactivated-TCID<sub>50</sub> doses are specified in <strong>Supplemental Table 1</strong>. Sera were collected 18 days after vaccination and pooled for each group. Serum nAb titers were measured against HRV-16, HRV-36, and HRV-78. The dashed line represents limit of detection (LOD). Error bars show 95% confidence interval. Data depict three independent experiments combined.</p><div class="sb-div caption-clear"></div></div></div><p id="p-8">In 1975, it was reported that two different 10-valent inactivated HRV preparations induced nAb titers to only 30-40% of the input virus types in recipient subjects<a id="xref-ref-33-1" class="xref-bibr" href="#ref-33"><sup>33</sup></a>. However, the input titers of viruses prior to inactivation ranged from 10<sup>1.5</sup> to 10<sup>5.5</sup> TCID<sub>50</sub> per ml, and these were then diluted 10-fold to generate 10-valent 1.0 ml doses given i.m. as prime and boost with no adjuvant<a id="xref-ref-33-2" class="xref-bibr" href="#ref-33"><sup>33</sup></a>. We hypothesized that low input antigen doses are responsible for poor nAb responses to 10-valent inactivated HRV. We reconstituted the 1975 10-valent vaccine, as closely as possible with available HRV types, over a 10<sup>1</sup> to 10<sup>5</sup> inactivated-TCID<sub>50</sub> per vaccine dose, and we compared it to a 10-valent vaccine of the same types with input titers ranging from &gt; 10<sup>5</sup> to &gt; 10<sup>7</sup> inactivated-TCID<sub>50</sub> per dose. The reconstituted 1975 vaccine resulted in no detectable nAb after prime vaccination and, following boost vaccination, nAb to the five types that had the highest input titers (<a id="xref-fig-2-1" class="xref-fig" href="#F2"><strong>Fig. 2</strong></a>). The high titer vaccine resulted in nAb to 5 of 10 types after prime vaccination and all 10 types after the boost (<a id="xref-fig-2-2" class="xref-fig" href="#F2"><strong>Fig. 2</strong></a>). Following the boost vaccinations, there appeared to be a 10<sup>4</sup> inactivated-TCID<sub>50</sub> per vaccine dose threshold for the induction of nAb in this model (<a id="xref-fig-2-3" class="xref-fig" href="#F2"><strong>Fig. 2b</strong></a>). Above this titer, there was no correlation between input load and nAb induction.</p><div id="F2" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Immunogenicity of inactivated polyvalent HRV is related to dose. Mice (2 groups, 20 per group) were vaccinated with 10-valent HRV vaccine consisting of low inactivated-TCID50 per dose input titers (x-axis), similar to the 1975 Hamory et al. study33, plus alum (gray symbols) or with 10-valent HRV vaccine with high inactivated-TCID50 per dose input titers plus alum (black symbols). Sera were collected 18 days after prime (A) and 18 days after boost (B), pooled for each group, and nAb titers (y-axis) were measured against the indicated types in the vaccines. The dashed line represents LOD. Undetectable nAb were assigned LOD/2, and some symbols below LOD were nudged for visualization. Three independent experiments using low input titers showed similar results. There was a statistically significant association between input TCID50 virus titer and a detectable nAb response following prime (P = 0.01) and boost (P = 0.03) vaccination (Fisher&#x2019;s exact test)." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1581022710" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Immunogenicity of inactivated polyvalent HRV is related to dose.&lt;/span&gt; Mice (2 groups, 20 per group) were vaccinated with 10-valent HRV vaccine consisting of low inactivated-TCID&lt;sub&gt;50&lt;/sub&gt; per dose input titers (&lt;em&gt;x&lt;/em&gt;-axis), similar to the 1975 Hamory et al. study&lt;sup&gt;33&lt;/sup&gt;, plus alum (gray symbols) or with 10-valent HRV vaccine with high inactivated-TCID&lt;sub&gt;50&lt;/sub&gt; per dose input titers plus alum (black symbols). Sera were collected 18 days after prime (&lt;strong&gt;A&lt;/strong&gt;) and 18 days after boost (&lt;strong&gt;B&lt;/strong&gt;), pooled for each group, and nAb titers (&lt;em&gt;y&lt;/em&gt;-axis) were measured against the indicated types in the vaccines. The dashed line represents LOD. Undetectable nAb were assigned LOD/2, and some symbols below LOD were nudged for visualization. Three independent experiments using low input titers showed similar results. There was a statistically significant association between input TCID&lt;sub&gt;50&lt;/sub&gt; virus titer and a detectable nAb response following prime (&lt;em&gt;P&lt;/em&gt; = 0.01) and boost (&lt;em&gt;P&lt;/em&gt; = 0.03) vaccination (Fisher&#x2019;s exact test).&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F2.medium.gif" width="239" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F2.medium.gif" width="239" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 2.</span> <span class="caption-title">Immunogenicity of inactivated polyvalent HRV is related to dose.</span><p id="p-9" class="first-child">Mice (2 groups, 20 per group) were vaccinated with 10-valent HRV vaccine consisting of low inactivated-TCID<sub>50</sub> per dose input titers (<em>x</em>-axis), similar to the 1975 Hamory et al. study<a id="xref-ref-33-3" class="xref-bibr" href="#ref-33"><sup>33</sup></a>, plus alum (gray symbols) or with 10-valent HRV vaccine with high inactivated-TCID<sub>50</sub> per dose input titers plus alum (black symbols). Sera were collected 18 days after prime (<strong>A</strong>) and 18 days after boost (<strong>B</strong>), pooled for each group, and nAb titers (<em>y</em>-axis) were measured against the indicated types in the vaccines. The dashed line represents LOD. Undetectable nAb were assigned LOD/2, and some symbols below LOD were nudged for visualization. Three independent experiments using low input titers showed similar results. There was a statistically significant association between input TCID<sub>50</sub> virus titer and a detectable nAb response following prime (<em>P</em> = 0.01) and boost (<em>P</em> = 0.03) vaccination (Fisher’s exact test).</p><div class="sb-div caption-clear"></div></div></div><p id="p-10">Injectable vaccines used in people are commonly given in a 0.5 ml dose. In our facility, the highest allowable i.m. vaccine volume in mice was 0.1 ml. We tested a 25-valent per 0.1 ml HRV vaccine in mice as a scalable prototype. The 25-valent inactivated HRV vaccine had a 7.4fold lower average inactivated-TCID<sub>50</sub> per type per dose than the 10-valent composition (<strong>Supplemental Table 2</strong>) to accommodate the volume adjustment. The 10-valent inactivated HRV vaccine induced nAb to 100% of input types following the prime and the boost (<a id="xref-fig-3-1" class="xref-fig" href="#F3"><strong>Fig. 3a)</strong></a>. The nAb induced by 10-valent inactivated HRV were persisting at 203 days post-boost (<strong>Supplemental Fig. 2</strong>). The 25-valent inactivated HRV prime vaccination induced nAb to 18 of 25 (72%) virus types, and the 25-valent boost resulted in nAb against 24 of the 25 types (96%) (<a id="xref-fig-3-2" class="xref-fig" href="#F3"><strong>Fig 3b</strong></a>). The average nAb titer resulting from prime + boost was 2<sup>7</sup> for 10-valent and 2<sup>6.8</sup> for 25-valent. The data demonstrate broad neutralization of diverse HRV types with a straightforward vaccine approach.</p><div id="F3" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Broad nAb responses against 10-valent and 25-valent inactivated HRV in mice. The inactivated-TCID50 input titers per dose are specified in Supplemental Table 2. A, 20 mice were vaccinated then boosted at 50 days with 10-valent HRV. B, 30 mice were vaccinated then boosted at 50 days with 25-valent HRV. Sera were collected at day 18 (prime) and day 68 (boost). nAb levels against the indicated types in the vaccines were measured in pooled sera. Error bars depict 95% confidence interval. Data shown represent one of three (10-valent) or two (25-valent) experiments with similar results. The dashed line represents LOD. Undetectable nAb were assigned LOD/2." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1581022710" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Broad nAb responses against 10-valent and 25-valent inactivated HRV in mice.&lt;/span&gt; The inactivated-TCID&lt;sub&gt;50&lt;/sub&gt; input titers per dose are specified in &lt;strong&gt;Supplemental Table 2. A&lt;/strong&gt;, 20 mice were vaccinated then boosted at 50 days with 10-valent HRV. &lt;strong&gt;B&lt;/strong&gt;, 30 mice were vaccinated then boosted at 50 days with 25-valent HRV. Sera were collected at day 18 (prime) and day 68 (boost). nAb levels against the indicated types in the vaccines were measured in pooled sera. Error bars depict 95% confidence interval. Data shown represent one of three (10-valent) or two (25-valent) experiments with similar results. The dashed line represents LOD. Undetectable nAb were assigned LOD/2.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F3.medium.gif" width="375" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F3.medium.gif" width="375" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 3.</span> <span class="caption-title">Broad nAb responses against 10-valent and 25-valent inactivated HRV in mice.</span><p id="p-11" class="first-child">The inactivated-TCID<sub>50</sub> input titers per dose are specified in <strong>Supplemental Table 2. A</strong>, 20 mice were vaccinated then boosted at 50 days with 10-valent HRV. <strong>B</strong>, 30 mice were vaccinated then boosted at 50 days with 25-valent HRV. Sera were collected at day 18 (prime) and day 68 (boost). nAb levels against the indicated types in the vaccines were measured in pooled sera. Error bars depict 95% confidence interval. Data shown represent one of three (10-valent) or two (25-valent) experiments with similar results. The dashed line represents LOD. Undetectable nAb were assigned LOD/2.</p><div class="sb-div caption-clear"></div></div></div><p id="p-12">In order to increase vaccine valency, we chose rhesus macaques (RMs) and a 1.0 ml i.m. vaccine volume. Two RMs were vaccinated with 25-valent inactivated HRV, and two RMs were vaccinated with 50-valent inactivated HRV. Pre-immune sera in RM A and RM B had no detectable nAb against the 25 HRV types included in the 25-valent vaccine. The inactivated-TCID<sub>50</sub> titers per dose were higher in RMs than in mice (<strong>Supplemental Table 3</strong>). The 25-valent vaccine induced nAb to 96% (RM A) and 100% (RM B) of input viruses following the prime vaccination (<a id="xref-fig-4-1" class="xref-fig" href="#F4"><strong>Fig. 4a</strong></a>). The 50-valent vaccine induced nAb to 90% (RM C) and 82% (RM D) of input viruses following the prime vaccination (<a id="xref-fig-4-2" class="xref-fig" href="#F4"><strong>Fig. 4c</strong></a>). The breadth of nAb following prime vaccination in RM was superior to what we observed in mice, which may have been due to animal species differences and/or higher inactivated-TCID<sub>50</sub> input titers in the RM vaccines. Following boost vaccination, there were serum nAb titers against 100% of the types in 25-valent HRV-vaccinated RMs (<a id="xref-fig-4-3" class="xref-fig" href="#F4"><strong>Fig. 4b</strong></a>) and 98% (49 out of 50) of the virus types in 50-valent HRV-vaccinated RMs (<a id="xref-fig-4-4" class="xref-fig" href="#F4"><strong>Fig. 4d</strong></a>). The average nAb titer resulting from prime + boost in RMs was 2<sup>9.3</sup> for 25-valent and 2<sup>8.6</sup> for 50-valent. The nAb responses were type-specific, not cross-neutralizing, because there were minimal nAbs induced by the 25-valent vaccine against 10 non-vaccine types (<strong>Supplemental Fig. 3</strong>). The nAb response to 50-valent inactivated HRV vaccine was broad and potent in RMs.</p><div id="F4" class="fig pos-float type-figure  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F4.large.jpg?width=800&amp;height=600&amp;carousel=1" title="Broad nAb responses against 25-valent and 50-valent inactivated HRV in rhesus macaques. The inactivated-TCID50 input titers per dose are specified in Supplemental Table 3. Two rhesus macaques (RM A and RM B) were vaccinated i.m. with 25-valent HRV + alum (A and B), and two rhesus macaques (RM C and RM D) were vaccinated i.m. with 50-valent HRV + alum (C and D). nAb titers against input virus types were measured in individual serum samples collected at day 18 (A and C). The RM received an identical boost vaccination at day 28, and sera were collected at day 46 for determining nAb titers post-boost vaccination (B and D). Error bars depict 95% confidence interval. The dashed line represents LOD. Undetectable nAb were assigned LOD/2." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1581022710" data-figure-caption="&lt;div class=&quot;highwire-markup&quot;&gt;&lt;div xmlns=&quot;http://www.w3.org/1999/xhtml&quot;&gt;&lt;span class=&quot;caption-title&quot;&gt;Broad nAb responses against 25-valent and 50-valent inactivated HRV in rhesus macaques.&lt;/span&gt; The inactivated-TCID&lt;sub&gt;50&lt;/sub&gt; input titers per dose are specified in &lt;strong&gt;Supplemental Table 3&lt;/strong&gt;. Two rhesus macaques (RM A and RM B) were vaccinated i.m. with 25-valent HRV + alum (&lt;strong&gt;A&lt;/strong&gt; and &lt;strong&gt;B&lt;/strong&gt;), and two rhesus macaques (RM C and RM D) were vaccinated i.m. with 50-valent HRV + alum (&lt;strong&gt;C&lt;/strong&gt; and &lt;strong&gt;D&lt;/strong&gt;). nAb titers against input virus types were measured in individual serum samples collected at day 18 (&lt;strong&gt;A&lt;/strong&gt; and &lt;strong&gt;C&lt;/strong&gt;). The RM received an identical boost vaccination at day 28, and sera were collected at day 46 for determining nAb titers post-boost vaccination (&lt;strong&gt;B&lt;/strong&gt; and &lt;strong&gt;D&lt;/strong&gt;). Error bars depict 95% confidence interval. The dashed line represents LOD. Undetectable nAb were assigned LOD/2.&lt;/div&gt;&lt;/div&gt;" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="Figure 4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F4.medium.gif" width="293" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="Figure 4." src="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F4.medium.gif" width="293" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="download-fig first"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4." data-icon-position="" data-hide-link-title="0">Download figure</a></li><li class="new-tab last"><a href="https://www.biorxiv.org/content/biorxiv/early/2016/05/17/053967/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li></ul></div><div class="fig-caption"><span class="fig-label">Figure 4.</span> <span class="caption-title">Broad nAb responses against 25-valent and 50-valent inactivated HRV in rhesus macaques.</span><p id="p-13" class="first-child">The inactivated-TCID<sub>50</sub> input titers per dose are specified in <strong>Supplemental Table 3</strong>. Two rhesus macaques (RM A and RM B) were vaccinated i.m. with 25-valent HRV + alum (<strong>A</strong> and <strong>B</strong>), and two rhesus macaques (RM C and RM D) were vaccinated i.m. with 50-valent HRV + alum (<strong>C</strong> and <strong>D</strong>). nAb titers against input virus types were measured in individual serum samples collected at day 18 (<strong>A</strong> and <strong>C</strong>). The RM received an identical boost vaccination at day 28, and sera were collected at day 46 for determining nAb titers post-boost vaccination (<strong>B</strong> and <strong>D</strong>). Error bars depict 95% confidence interval. The dashed line represents LOD. Undetectable nAb were assigned LOD/2.</p><div class="sb-div caption-clear"></div></div></div><p id="p-14">Based on our results and doses of early immunogenic HRV vaccines<a id="xref-ref-6-1" class="xref-bibr" href="#ref-6"><sup>6</sup></a>,<a id="xref-ref-8-2" class="xref-bibr" href="#ref-8"><sup>8</sup></a>, we estimate 10<sup>4-5</sup> inactivated-TCID<sub>50</sub> per type per dose will be useful. Therefore, HRV stock titers ≥ 10<sup>7</sup> TCID<sub>50</sub> per ml are required for a potential 83-valent HRV A formulation in a 0.5 ml dose containing alum adjuvant. The HRV stocks used in our vaccinations were produced in H1-HeLa cells, a good substrate for HRV replication but not suitable for vaccine manufacturing. We compared the infectious yield of 10 HRV types in H1-HeLa and WI-38, which can be qualified for vaccine production. Adequate yields were obtained from WI-38 cells (<strong>Supplemental Fig. 4</strong>). Injectable vaccines require defined purity. As proof of principle, we purified three HRV types by high performance liquid chromatography and found uncompromised immunogenicity of trivalent inactivated purified HRV in mice (<strong>Supplemental Fig. 5</strong>).</p><p id="p-15">Forty years ago, the prospects for a polyvalent HRV vaccine were dour for good reasons<a id="xref-ref-17-2" class="xref-bibr" href="#ref-17"><sup>17</sup></a>. However, progress in technology<a id="xref-ref-34-1" class="xref-bibr" href="#ref-34"><sup>34</sup></a> and advancement of more complex vaccines renders impediments to a polyvalent HRV vaccine manageable. Scale-up of HRV vaccines may be facilitated by related vaccine production processes and new cost-saving manufacturing technologies<a id="xref-ref-35-1" class="xref-bibr" href="#ref-35"><sup>35</sup></a><sup>−</sup><a id="xref-ref-37-1" class="xref-bibr" href="#ref-37"><sup>37</sup></a>. We provide proof of principle that broad nAb responses can be induced by vaccination with a 50-valent inactivated HRV vaccine plus alum adjuvant. Inactivated HRV has a positive history of clinical efficacy<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6"><sup>6</sup></a>,<a id="xref-ref-8-3" class="xref-bibr" href="#ref-8"><sup>8</sup></a>,<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9"><sup>9</sup></a>. In future studies, we hope to produce a comprehensive 83-valent HRV A vaccine and generate HRV C vaccines. Our approach may lead to vaccines for rhinovirus-mediated diseases including asthma and COPD exacerbations and the common cold. Advancing valency may be applicable to vaccines for other antigenically variable pathogens.</p></div><div class="section" id="sec-3"><h2 class="">ONLINE METHODS</h2><p id="p-16">No statistical methods were used in predetermining sample sizes.</p><div id="sec-4" class="subsection"><h3>Cell lines and viruses</h3><p id="p-17">H1-HeLa (CRL-1958) and WI38 (CCL-75) cells were obtained from the American Type Culture Collection (ATCC) and cultured in minimal essential media with Richter’s modification and no phenol red (MEM) (ThermoFisher) supplemented with 10 % fetal bovine serum. The cell lines were not authenticated but are not commonly misidentified (International Cell Line Authentication Committee). We tested HeLa-H1 cells using the LookOut Mycoplasma detection kit (Sigma), and these were mycoplasma negative. HRV-7 (VR-1601), HRV-9 (VR-1745), HRV-11 (VR-1567), HRV-13 (VR-286), HRV-14 (VR-284), HRV-16 (VR-283), HRV-19 (V4-1129), HRV-24 (VR-1134), HRV-29 (VR-1809), HRV-30 (VR-1140), HRV-31 (VR-1795), HRV-32 (VR-329), HRV-36 (VR-509), HRV-38 (VR-511), HRV-40 (VR-341), HRV-41 (VR-1151), HRV-49 (VR-1644), HRV-53 (VR-1163), HRV-56 (VR-1166), HRV-58 (VR-1168), HRV-59 (VR-1169), HRV-60 (VR-1473), HRV-64 (VR-1174), HRV-66 (VR-1176), HRV-68 (VR-1178), HRV-75 (VR-1185), HRV-76 (VR-1186), HRV-77 (VR-1187), HRV-78 (VR-1188), HRV-80 (VR-1190), HRV-81 (VR-1191), HRV-85 (VR-1195), HRV-88 (VR-1198), HRV-89 (VR-1199), HRV-96 (VR-1296), and HRV-100 (VR-1300) prototype strains were purchased from ATCC. HRV-1B, HRV-10, HRV-21, HRV-28, HRV-33, HRV-34, HRV-39, HRV-45, HRV-50, HRV-51, HRV-54, HRV-55, HRV-94 strains were obtained from the Centers for Disease Control and Prevention. The HRVs in the study are species A, with the exception of HRV-14 (B), and represent A species broadly<a id="xref-ref-20-2" class="xref-bibr" href="#ref-20"><sup>20</sup></a>,<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21"><sup>21</sup></a>.</p></div><div id="sec-5" class="subsection"><h3>HRV propagation and titration</h3><p id="p-18">HRV stocks were generated in H1-HeLa cells. Approximately 0.5 ml of HRV was inoculated onto subconfluent H1-HeLa monolayer cells in a T-182 flask. After adsorption for 1 hr at room temperature with rocking, 50 ml of HRV infection medium (MEM supplemented with 2 % FBS, 20 mM HEPES, 10 mM MgCl<sub>2</sub>, 1X non-essential amino acids [Gibco catalog 11140-050]) was added and the infection was allowed to proceed at 32°C in a 5% CO<sub>2</sub> humidified incubator until the monolayer appeared to be completely involved with cytopathic effect (CPE), 1 to 3 days post-infection. The cells were scraped, and the cells and medium (approximately 50 ml) were transferred to two pre-chilled 50 ml conical polypropylene tubes and kept on ice while each suspension was sonicated using a Sonic Dismembrator Model 500 (Fisher Scientific) equipped with a ½-inch diameter horn disrupter and ¼-inch diameter tapered microtip secured on a ring stand. Sonication was performed by an operator in a closed room with ear protection, at 10 % amplitude, 1 sec on/1 sec off intervals, and 1 pulse per 1 ml of material. Sonication yielded higher titers than freeze-thaw. The suspension was clarified by centrifugation at 931 × <em>g</em> for 10 minutes. The supernatant was transferred to cryovials, snap-frozen in liquid nitrogen, and stored at −80°C. For comparing HRV yield in H1-HeLa and WI-38 cells, T-75 flasks of subconfluent cells were infected at a multiplicity of infection (MOI) of 0.1 TCID<sub>50</sub>/cell, and 20 ml of culture medium were discarded prior to scraping the cells in the remaining 5 ml followed by sonication. For all stocks, TCID<sub>50</sub>/ml titers were determined by infecting subconfluent H1-HeLa cells in 96-well plates with serially diluted samples, staining the cells six days post-infection with 0.1% crystal violet/20% methanol, scoring wells for CPE, and calculating the endpoint titer using the Reed and Muench method<a id="xref-ref-38-1" class="xref-bibr" href="#ref-38"><sup>38</sup></a>.</p></div><div id="sec-6" class="subsection"><h3>HRV Purification</h3><p id="p-19">HRV stock was harvested from H1-HeLa cell monolayers as describe above and clarified by brief centrifugation at low speed to remove large cellular debris (931 × <em>g</em>, 10 min, 4°C). In order to remove excess albumin from the crude virus stock by affinity chromatography, the supernatant was loaded onto a HiTrap Blue HP column (GE Healthcare) using an ÄKTAPurifier system (GE Healthcare) according to the manufacturer specifications. Flowthrough was subsequently loaded through a HiTrap Capto Core 700 column (GE Healthcare) to refine the virus prep by size exclusion chromatography (SEC). The flowthrough from the HiTrap Blue HP and the HiTrap Capto Core 700 was captured using the ÄKTAPurifier system (GE Healthcare) with a 20 mM sodium phosphate buffer (pH 7.0). Flowthrough from SEC was dialyzed overnight with 0.1 M Tris-HCl buffer (pH 8.0), then loaded onto a HiTrap Q XL column (GE Healthcare) and separated into fractions by ion exchange chromatography. Virus-containing fractions were eluted using the ÄKTAPurifier system (GE Healthcare) with a 0.1 M Tris-HCl buffer (pH 8.0) and a sodium chloride gradient. Fractions showing high absorption peaks at 280 nM were collected and analyzed for viral titer by TCID<sub>50</sub> end-point dilution assay, and fraction purity visualized on a 10% SDS-PAGE gel by silver stain (Thermo Fisher Scientific) (<strong>Supplemental Figure 6</strong>). Fractions of HRV-16, HRV-36, and HRV-78 of high virus titer and purity were combined for formalin-inactivation as described below.</p></div><div id="sec-7" class="subsection"><h3>Mice and Rhesus macaques</h3><p id="p-20">All experiments involving animals were conducted at Emory University and the Yerkes National Primate Research Center in accordance with guidelines established by the Animal Welfare Act and the NIH Guide for the Care and Use of Laboratory Animals. Animal facilities at Emory University and the Yerkes Center are fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC). The Institutional Animal Care and Use Committee (IACUC) of Emory University approved these studies. Pathogen-free, 6-7-week female BALB/c mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). Mice were randomly assigned to groups based on sequential selection from an inventory, and investigators were not blinded to outcome assessment.</p><p id="p-21">Young adult (3 - 5 kg, 2 - 4 years of age, 2 females and 2 males) Indian rhesus macaques (<em>Macaca mulatta;</em> RM) were maintained according to NIH guidelines at the Yerkes National Primate Research Center. Handling and movement of RMs was performed by qualified personnel who have received specific training in safe and humane methods of animal handling at the Yerkes National Primate Research Center. The initial exclusion criterion was pre-existing nAb against HRV. The studies were conducted in strict accordance with US Department of Agriculture regulations and the recommendations in the Guide for Care and Use of Laboratory Animals of the NIH. The RMs were allocated in an un-blinded fashion to two vaccine groups (25-valent and 50-valent), one male and one female per group.</p></div><div id="sec-8" class="subsection"><h3>Vaccination</h3><p id="p-22">Before immunization, all HRV types were inactivated by addition of 0.025% formalin followed by incubation with stirring for 72 hr at 37°C, as previously described for HRV vaccine<a id="xref-ref-33-4" class="xref-bibr" href="#ref-33"><sup>33</sup></a>. Complete inactivation of infectivity was confirmed by end-point TCID<sub>50</sub> titration in H1-HeLa cells. Formalin inactivation by this method resulted in greater immunogenicity in mice than alternative inactivation by beta-propiolactone, suggesting formalin inactivation preserved antigenic determinants. Mice were vaccinated i.m. with inactivated HRV strains mixed with 100 μg of Alhydrogel adjuvant 2% (aluminum hydroxide wet gel suspension, alum) (Sigma catalog A8222 or Invivogen catalog vac-alu) according instructions of the manufacturers. The total volume per mouse was 100 μl, administered in 50 μl per thigh. Mice were given a second identical vaccination (boost) at the time indicated in figure legends. RMs were vaccinated i.m. with inactivated HRV strains mixed with 500 μg of Alhydrogel adjuvant 2%. The total volume per RM was 1 ml, administered in one leg. RMs were boosted with an identical vaccination at four weeks.</p></div></div><div class="section" id="sec-9"><h2 class="">Serum collection</h2><p id="p-23">In mice, peripheral blood was collected into microcentrifuge tubes from the submandibular vein. Samples were incubated at room temperature for 20 min to clot. The tubes were centrifuged 7500 × g for 10 min to separate serum. The serum samples were pooled from mice of each group and stored at −80 °C until used. Phlebotomy involving RMs was performed under either ketamine (10 mg/kg) or Telazol (4 mg/kg) anesthesia on fasting animals. Following anesthesia with ketamine or Telazol, the animals were bled from the femoral vein. Yerkes blood collection guidelines were followed and no more than 10 ml/kg/28 days of blood was collected. After collecting blood in serum separating tube (SST), samples were incubated at room temperature for 30 min. The tubes were centrifuged 2500 × g for 15 min to separate serum. The serum samples from individual RM were stored at −80 °C until used.</p><div id="sec-10" class="subsection"><h3>Serum neutralization assay</h3><p id="p-24">H1-HeLa cells were seeded in 96-well plates to attain 80-90 % confluence in 24 h. Heat-inactivated (56°C, 30 min) serum samples were 2-fold serially diluted in MEM and added to 500 TCID<sub>50</sub>/mL HRV of each type to be tested, in an equal volume. The virus and serum mixtures were incubated 37°C for 1 h. Then, 50 μl of the serum-virus mixture was transferred onto H1-HeLa cell monolayers in 96-well plates in triplicate, and plates were spinoculated at 2,095 × <em>g</em> for 30 min at 4°C. For each type, a no-serum control was added to test the input 500 TCID<sub>50</sub>. We tested pooled HRV-16 anti-sera against HRV-16 in each assay as a standard. After spinoculation, 150 μl of HRV infection medium were added to each well. The 96-well plates were incubated for 6 days at 32°C and 5% CO<sub>2</sub> and then stained with crystal violet as described above. Wells were scored for the presence or absence of CPE. Neutralizing antibody endpoint titers and 95% confidence intervals were determined by the method of Reed and Muench, as previously described for HRV<a id="xref-ref-14-2" class="xref-bibr" href="#ref-14"><sup>14</sup></a>,<a id="xref-ref-8-4" class="xref-bibr" href="#ref-8"><sup>38</sup></a>. The 95% confidence interval indicates variability of three technical replicates within a single nAb experiment.</p></div></div><div id="sec-11" class="subsection"><p id="p-25">Supplementary Information is available in the online version of the paper.</p></div><div class="section" id="sec-12"><h2 class="">Author Contributions</h2><p id="p-27">S.L. and M.T.N. contributed equally. S.L., M.T.N., M.G.C., J.B.J, E.A.S, A.E.K., and R.M.L. performed experiments. K.R., Y.A.B., J.E.G, and P.S. provided reagents and advice. X.L. and D.D.E. provided rhinovirus types. S.L., M.T.N., and M.L.M designed the experiments, analyzed data, and wrote the paper.</p></div><div class="section" id="sec-13"><h2 class="">Competing Interests</h2><p id="p-28">The authors declare competing financial interests: M.L.M co-founded Meissa Vaccines, Inc. and serves as Chief Scientific Officer for the Company. S.L., M.T.N., and M.L.M are co-inventors of rhinovirus vaccine subject to evaluation in this paper. The vaccine technology has been optioned to Meissa by Emory University.</p></div><div class="section ack" id="ack-1"><h2 class="">Acknowledgements</h2><p id="p-26">We are indebted to the Yerkes veterinary personnel for providing technical assistance. We thank Max Cooper (Emory University) and Joshy Jacob (Emory University) for helpful discussions. This study was supported by a pilot grant from the Emory+Children’s Center for Childhood Infections and Vaccines (CCIV) to M.L.M and in part by Department of Health and Human Services, National Institutes of Health grants 1R01AI087798 and 1U19AI095227 to M.L.M. This work is dedicated to A.R.</p></div><div class="section ref-list" id="ref-list-1"><h2 class="">References</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.1" data-doi="10.1056/NEJM196612082752301"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Gwaltney</span>,  <span class="cit-name-given-names">J. M.</span>,   <span class="cit-name-suffix">Jr.</span>.</span>, <span class="cit-auth"><span class="cit-name-surname">Hendley</span>,  <span class="cit-name-given-names">J. O.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Simon</span>,  <span class="cit-name-given-names">G.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Jordan</span>,  <span class="cit-name-given-names">W. S.</span>,   <span class="cit-name-suffix">Jr.</span>.</span> <span class="cit-article-title">Rhinovirus infections in an industrial population. I. The occurrence of illness</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr> <span class="cit-vol">275</span>, <span class="cit-fpage">1261</span>–<span class="cit-lpage">1268</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1056/NEJM196612082752301</span> (<span class="cit-pub-date">1966</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DGwaltney%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D275%26rft.issue%253D23%26rft.spage%253D1261%26rft.epage%253D1268%26rft.atitle%253DRhinovirus%2Binfections%2Bin%2Ban%2Bindustrial%2Bpopulation.%2BI.%2BThe%2Boccurrence%2Bof%2Billness.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM196612082752301%26rft_id%253Dinfo%253Apmid%252F4288780%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJM196612082752301&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=4288780&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A19668587100001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.2" data-doi="10.1016/j.coviro.2015.03.004"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Glanville</span>,  <span class="cit-name-given-names">N.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Johnston</span>,  <span class="cit-name-given-names">S. L.</span></span> <span class="cit-article-title">Challenges in developing a cross-serotype rhinovirus vaccine</span>. <abbr class="cit-jnl-abbrev">Curr Opin Virol</abbr> <span class="cit-vol">11</span>, <span class="cit-fpage">83</span>–<span class="cit-lpage">88</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1016/j.coviro.2015.03.004</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DCurr%2BOpin%2BVirol%26rft.volume%253D11%26rft.spage%253D83%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.coviro.2015.03.004%26rft_id%253Dinfo%253Apmid%252F25829255%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.coviro.2015.03.004&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25829255&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.3" data-doi="10.1056/NEJMoa1500245"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jain</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr> <span class="cit-vol">373</span>, <span class="cit-fpage">415</span>–<span class="cit-lpage">427</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa1500245</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D373%26rft.spage%253D415%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1500245%26rft_id%253Dinfo%253Apmid%252F26172429%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa1500245&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=26172429&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.4" data-doi="10.1056/NEJMoa1405870"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Jain</span>,  <span class="cit-name-given-names">S.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Community-acquired pneumonia requiring hospitalization among U.S. children</span>. <abbr class="cit-jnl-abbrev">N Engl J Med</abbr> <span class="cit-vol">372</span>, <span class="cit-fpage">835</span>–<span class="cit-lpage">845</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1056/NEJMoa1405870</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D372%26rft.spage%253D835%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa1405870%26rft_id%253Dinfo%253Apmid%252F25714161%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa1405870&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25714161&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.5" data-doi="10.1017/S095026880003106X"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Barclay</span>,  <span class="cit-name-given-names">W. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">al-Nakib</span>,  <span class="cit-name-given-names">W.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Higgins</span>,  <span class="cit-name-given-names">P. G.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Tyrrell</span>,  <span class="cit-name-given-names">D. A.</span></span> <span class="cit-article-title">The time course of the humoral immune response to rhinovirus infection</span>. <abbr class="cit-jnl-abbrev">Epidemiol Infect</abbr> <span class="cit-vol">103</span>, <span class="cit-fpage">659</span>–<span class="cit-lpage">669</span> (<span class="cit-pub-date">1989</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEpidemiology%2Band%2BInfection%2B%2528Print%2529%26rft.stitle%253DEpidemiology%2Band%2BInfection%2B%2528Print%2529%26rft.aulast%253DBarclay%26rft.auinit1%253DW.%2BS.%26rft.volume%253D103%26rft.issue%253D3%26rft.spage%253D659%26rft.epage%253D669%26rft.atitle%253DThe%2Btime%2Bcourse%2Bof%2Bthe%2Bhumoral%2Bimmune%2Bresponse%2Bto%2Brhinovirus%2Binfection.%26rft_id%253Dinfo%253Adoi%252F10.1017%252FS095026880003106X%26rft_id%253Dinfo%253Apmid%252F2558033%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1017/S095026880003106X&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=2558033&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.6" data-doi="10.1136/bmj.1.5322.34"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Doggett</span>,  <span class="cit-name-given-names">J. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Bynoe</span>,  <span class="cit-name-given-names">M. L.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Tyrrell</span>,  <span class="cit-name-given-names">D. A.</span></span> <span class="cit-article-title">Some attempts to produce an experimental vaccine with rhinoviruses</span>. <abbr class="cit-jnl-abbrev">Br Med J</abbr> <span class="cit-vol">1</span>, <span class="cit-fpage">34</span>–<span class="cit-lpage">36</span> (<span class="cit-pub-date">1963</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.aulast%253DDoggett%26rft.auinit1%253DJ.%2BE.%26rft.volume%253D1%26rft.issue%253D5322%26rft.spage%253D34%26rft.epage%253D36%26rft.atitle%253DSome%2BAttempts%2Bto%2BProduce%2Ban%2BExperimental%2BVaccine%2Bwith%2BRhinoviruses%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.1.5322.34%26rft_id%253Dinfo%253Apmid%252F14028369%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czozOiJibWoiO3M6NToicmVzaWQiO3M6OToiMS81MzIyLzM0IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">7.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.7" data-doi="10.1001/jama.1963.63710060029013"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Mufson</span>,  <span class="cit-name-given-names">M. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Effect of Neutralizing Antibody on Experimental Rhinovirus Infection</span>. <abbr class="cit-jnl-abbrev">Jama</abbr> <span class="cit-vol">186</span>, <span class="cit-fpage">578</span>–<span class="cit-lpage">584</span> (<span class="cit-pub-date">1963</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJAMA%26rft.stitle%253DJAMA%26rft.aulast%253DMufson%26rft.auinit1%253DM.%2BA.%26rft.volume%253D186%26rft.issue%253D6%26rft.spage%253D578%26rft.epage%253D584%26rft.atitle%253DEffect%2Bof%2BNeutralizing%2BAntibody%2Bon%2BExperimental%2BRhinovirus%2BInfection%26rft_id%253Dinfo%253Adoi%252F10.1001%252Fjama.1963.63710060029013%26rft_id%253Dinfo%253Apmid%252F14059033%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1001/jama.1963.63710060029013&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=14059033&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.8"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Perkins</span>,  <span class="cit-name-given-names">J. C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route</span>. <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-vol">90</span>, <span class="cit-fpage">319</span>–<span class="cit-lpage">326</span> (<span class="cit-pub-date">1969</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAmerican%2BJournal%2Bof%2BEpidemiology%26rft.stitle%253DAm%2BJ%2BEpidemiol%26rft.aulast%253DPERKINS%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D90%26rft.issue%253D4%26rft.spage%253D319%26rft.epage%253D326%26rft.atitle%253DEVIDENCE%2BFOR%2BPROTECTIVE%2BEFFECT%2BOF%2BAN%2BINACTIVATED%2BRHINOVIRUS%2BVACCINE%2BADMINISTERED%2BBY%2BTHE%2BNASAL%2BROUTE%26rft_id%253Dinfo%253Apmid%252F4309899%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=4309899&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1969E466700007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.9"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Perkins</span>,  <span class="cit-name-given-names">J. C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness</span>. <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-vol">90</span>, <span class="cit-fpage">519</span>–<span class="cit-lpage">526</span> (<span class="cit-pub-date">1969</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAmerican%2BJournal%2Bof%2BEpidemiology%26rft.stitle%253DAm%2BJ%2BEpidemiol%26rft.aulast%253DPERKINS%26rft.auinit1%253DJ.%2BC.%26rft.volume%253D90%26rft.issue%253D6%26rft.spage%253D519%26rft.epage%253D526%26rft.atitle%253DCOMPARISON%2BOF%2BPROTECTIVE%2BEFFECT%2BOF%2BNEUTRALIZING%2BANTIBODY%2BIN%2BSERUM%2BAND%2BNASAL%2BSECRETIONS%2BIN%2BEXPERIMENTAL%2BRHINOVIRUS%2BTYPE%2B13%2BILLNESS%26rft_id%253Dinfo%253Apmid%252F4312066%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=4312066&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1969F089200007&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.10"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Buscho</span>,  <span class="cit-name-given-names">R. F.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Perkins</span>,  <span class="cit-name-given-names">J. C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Knopf</span>,  <span class="cit-name-given-names">H. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kapikian</span>,  <span class="cit-name-given-names">A. Z.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Chanock</span>,  <span class="cit-name-given-names">R. M.</span></span> <span class="cit-article-title">Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine</span>. <abbr class="cit-jnl-abbrev">J Immunol</abbr> <span class="cit-vol">108</span>, <span class="cit-fpage">169</span>–<span class="cit-lpage">177</span> (<span class="cit-pub-date">1972</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BJournal%2Bof%2BImmunology%26rft.stitle%253DJ.%2BImmunol.%26rft.aulast%253DBuscho%26rft.auinit1%253DR.%2BF.%26rft.volume%253D108%26rft.issue%253D1%26rft.spage%253D169%26rft.epage%253D177%26rft.atitle%253DFurther%2BCharacterization%2Bof%2Bthe%2BLocal%2BRespiratory%2BTract%2BAntibody%2BResponse%2BInduced%2Bby%2BIntranasal%2BInstillation%2Bof%2BInactivated%2BRhinovirus%2B13%2BVaccine%26rft_id%253Dinfo%253Apmid%252F4334548%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6ODoiamltbXVub2wiO3M6NToicmVzaWQiO3M6OToiMTA4LzEvMTY5IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.11" data-doi="10.1136/bmj.1.5446.1344"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Mitchison</span>,  <span class="cit-name-given-names">D. A.</span></span> <span class="cit-article-title">Prevention of Colds by Vaccination against a Rhinovirus: A Report by the Scientific Committee on Common Cold Vaccines</span>. <abbr class="cit-jnl-abbrev">Br Med J</abbr> <span class="cit-vol">1</span>, <span class="cit-fpage">1344</span>–<span class="cit-lpage">1349</span> (<span class="cit-pub-date">1965</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBMJ%26rft.stitle%253DBMJ%26rft.aulast%253DMitchison%26rft.auinit1%253DD.%2BA.%26rft.volume%253D1%26rft.issue%253D5446%26rft.spage%253D1344%26rft.epage%253D1349%26rft.atitle%253DPrevention%2Bof%2BColds%2Bby%2BVaccination%2Bagainst%2Ba%2BRhinovirus%253A%2BA%2BReport%2Bby%2Bthe%2BScientific%2BCommittee%2Bon%2BCommon%2BCold%2BVaccines%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.1.5446.1344%26rft_id%253Dinfo%253Apmid%252F14278839%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6MzoiUERGIjtzOjExOiJqb3VybmFsQ29kZSI7czozOiJibWoiO3M6NToicmVzaWQiO3M6MTE6IjEvNTQ0Ni8xMzQ0IjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.12"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Stott</span>,  <span class="cit-name-given-names">E. J.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Draper</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Stons</span>,  <span class="cit-name-given-names">P. B.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Tyrrell</span>,  <span class="cit-name-given-names">D. A.</span></span> <span class="cit-article-title">Absence of heterologous antibody responses in human volunteers after rhinovirus vaccination. (Brief report)</span>. <abbr class="cit-jnl-abbrev">Arch Gesamte Virusforsch</abbr> <span class="cit-vol">28</span>, <span class="cit-fpage">89</span>–<span class="cit-lpage">92</span> (<span class="cit-pub-date">1969</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DArchiv%2Bf%25C3%25BCr%2Bdie%2Bgesamte%2BVirusforschung%26rft.stitle%253DArch%2BGesamte%2BVirusforsch%26rft.aulast%253DStott%26rft.auinit1%253DE.%2BJ.%26rft.volume%253D28%26rft.issue%253D1%26rft.spage%253D89%26rft.epage%253D92%26rft.atitle%253DAbsence%2Bof%2Bheterologous%2Bantibody%2Bresponses%2Bin%2Bhuman%2Bvolunteers%2Bafter%2Brhinovirus%2Bvaccination.%2B%2528Brief%2Breport%2529.%26rft_id%253Dinfo%253Apmid%252F4315817%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=4315817&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.13" data-doi="10.1371/journal.ppat.1003669"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Glanville</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Cross-serotype immunity induced by immunization with a conserved rhinovirus capsid protein</span>. <abbr class="cit-jnl-abbrev">PLoS Pathog</abbr> <span class="cit-vol">9</span>, <span class="cit-fpage">e1003669</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1371/journal.ppat.1003669</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BPathog%26rft.volume%253D9%26rft.spage%253De1003669%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.ppat.1003669%26rft_id%253Dinfo%253Apmid%252F24086140%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.ppat.1003669&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=24086140&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.14"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Cooney</span>,  <span class="cit-name-given-names">M. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Fox</span>,  <span class="cit-name-given-names">J. P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Kenny</span>,  <span class="cit-name-given-names">G. E.</span></span> <span class="cit-article-title">Antigenic groupings of 90 rhinovirus serotypes</span>. <abbr class="cit-jnl-abbrev">Infect Immun</abbr> <span class="cit-vol">37</span>, <span class="cit-fpage">642</span>–<span class="cit-lpage">647</span> (<span class="cit-pub-date">1982</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DCooney%26rft.auinit1%253DM%2BK%26rft.volume%253D37%26rft.issue%253D2%26rft.spage%253D642%26rft.epage%253D647%26rft.atitle%253DAntigenic%2Bgroupings%2Bof%2B90%2Brhinovirus%2Bserotypes.%26rft_id%253Dinfo%253Apmid%252F6288568%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjg6IjM3LzIvNjQyIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.15" data-doi="10.1016/j.antiviral.2012.06.006"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">McLean</span>,  <span class="cit-name-given-names">G. R.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Rhinovirus infections and immunisation induce cross-serotype reactive antibodies to VP1</span>. <abbr class="cit-jnl-abbrev">Antiviral Res</abbr> <span class="cit-vol">95</span>, <span class="cit-fpage">193</span>–<span class="cit-lpage">201</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1016/j.antiviral.2012.06.006</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntiviral%2Bresearch%26rft.stitle%253DAntiviral%2BRes%26rft.aulast%253DMcLean%26rft.auinit1%253DG.%2BR.%26rft.volume%253D95%26rft.issue%253D3%26rft.spage%253D193%26rft.epage%253D201%26rft.atitle%253DRhinovirus%2Binfections%2Band%2Bimmunisation%2Binduce%2Bcross-serotype%2Breactive%2Bantibodies%2Bto%2BVP1.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.antiviral.2012.06.006%26rft_id%253Dinfo%253Apmid%252F22742898%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.antiviral.2012.06.006&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22742898&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.16" data-doi="10.1093/infdis/150.2.167"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Couch</span>,  <span class="cit-name-given-names">R. B.</span></span> <span class="cit-article-title">The common cold: control?</span> <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-vol">150</span>, <span class="cit-fpage">167</span>–<span class="cit-lpage">173</span> (<span class="cit-pub-date">1984</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F150.2.167%26rft_id%253Dinfo%253Apmid%252F6206168%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/150.2.167&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=6206168&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1984TH02300001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.17"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Fox</span>,  <span class="cit-name-given-names">J. P.</span></span> <span class="cit-article-title">Is a rhinovirus vaccine possible?</span> <abbr class="cit-jnl-abbrev">Am J Epidemiol</abbr> <span class="cit-vol">103</span>, <span class="cit-fpage">345</span>–<span class="cit-lpage">354</span> (<span class="cit-pub-date">1976</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAmerican%2BJournal%2Bof%2BEpidemiology%26rft.stitle%253DAm%2BJ%2BEpidemiol%26rft.aulast%253DFOX%26rft.auinit1%253DJ.%2BP.%26rft.volume%253D103%26rft.issue%253D4%26rft.spage%253D345%26rft.epage%253D354%26rft.atitle%253DIS%2BA%2BRHINOVIRUS%2BVACCINE%2BPOSSIBLE%253F%26rft_id%253Dinfo%253Apmid%252F176887%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=176887&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1976BN07200001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.18" data-doi="10.1126/scitranslmed.3007118"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Crowe</span>,  <span class="cit-name-given-names">J. E.</span>,   <span class="cit-name-suffix">Jr.</span>.</span> <span class="cit-article-title">Universal flu vaccines: primum non nocere</span>. <abbr class="cit-jnl-abbrev">Sci Transl Med</abbr> <span class="cit-vol">5</span>, <span class="cit-fpage">200fs234</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1126/scitranslmed.3007118</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DSci%2BTransl%2BMed%26rft.volume%253D5%26rft.spage%253D200fs234%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscitranslmed.3007118%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1126/scitranslmed.3007118&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.19" data-doi="10.1073/pnas.1312146110"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Vollmers</span>,  <span class="cit-name-given-names">C.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sit</span>,  <span class="cit-name-given-names">R. V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Weinstein</span>,  <span class="cit-name-given-names">J. A.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Dekker</span>,  <span class="cit-name-given-names">C. L.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Quake</span>,  <span class="cit-name-given-names">S. R.</span></span> <span class="cit-article-title">Genetic measurement of memory B-cell recall using antibody repertoire sequencing</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-vol">110</span>, <span class="cit-fpage">13463</span>–<span class="cit-lpage">13468</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1073/pnas.1312146110</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BU%2BS%2BA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1312146110%26rft_id%253Dinfo%253Apmid%252F23898164%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTEwLzMzLzEzNDYzIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.20" data-doi="10.1099/vir.0.053686-0"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">McIntyre</span>,  <span class="cit-name-given-names">C. L.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Knowles</span>,  <span class="cit-name-given-names">N. J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Simmonds</span>,  <span class="cit-name-given-names">P.</span></span> <span class="cit-article-title">Proposals for the classification of human rhinovirus species A, B and C into genotypically assigned types</span>. <abbr class="cit-jnl-abbrev">J Gen Virol</abbr> <span class="cit-vol">94</span>, <span class="cit-fpage">1791</span>–<span class="cit-lpage">1806</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1099/vir.0.053686-0</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BGen%2BVirol%26rft_id%253Dinfo%253Adoi%252F10.1099%252Fvir.0.053686-0%26rft_id%253Dinfo%253Apmid%252F23677786%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1099/vir.0.053686-0&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=23677786&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000322850200011&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.21" data-doi="10.1126/science.1165557"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Palmenberg</span>,  <span class="cit-name-given-names">A. C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution</span>. <abbr class="cit-jnl-abbrev">Science</abbr> <span class="cit-vol">324</span>, <span class="cit-fpage">55</span>–<span class="cit-lpage">59</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1126/science.1165557</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.1165557%26rft_id%253Dinfo%253Apmid%252F19213880%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjExOiIzMjQvNTkyMy81NSI7czo0OiJhdG9tIjtzOjM3OiIvYmlvcnhpdi9lYXJseS8yMDE2LzA1LzE3LzA1Mzk2Ny5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.22" data-doi="10.1164/rccm.201202-0330OC"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lee</span>,  <span class="cit-name-given-names">W. M.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Human rhinovirus species and season of infection determine illness</span> <abbr class="cit-jnl-abbrev">severity. Am J Respir Crit Care Med</abbr> <span class="cit-vol">186</span>, <span class="cit-fpage">886</span>–<span class="cit-lpage">891</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1164/rccm.201202-0330OC</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253Dseverity.%2BAm%2BJ%2BRespir%2BCrit%2BCare%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1164%252Frccm.201202-0330OC%26rft_id%253Dinfo%253Apmid%252F22923659%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1164/rccm.201202-0330OC&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=22923659&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000311128300015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.23" data-doi="10.1016/j.jaci.2008.10.007"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Miller</span>,  <span class="cit-name-given-names">E. K.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">A novel group of rhinoviruses is associated with asthma hospitalizations</span>. <abbr class="cit-jnl-abbrev">J Allergy Clin Immunol</abbr> <span class="cit-vol">123</span>, <span class="cit-fpage">98</span>–<span class="cit-lpage">104e101</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">S0091-6749(08)01847-2 [pii]10.1016/j.jaci.2008.10.007</span> (<span class="cit-pub-date">2009</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BAllergy%2Band%2BClinical%2BImmunology%26rft.stitle%253DJournal%2Bof%2BAllergy%2Band%2BClinical%2BImmunology%26rft.aulast%253DMiller%26rft.auinit1%253DE.%2BK.%26rft.volume%253D123%26rft.issue%253D1%26rft.spage%253D98%26rft.epage%253D104.e1%26rft.atitle%253DA%2Bnovel%2Bgroup%2Bof%2Brhinoviruses%2Bis%2Bassociated%2Bwith%2Basthma%2Bhospitalizations.%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.jaci.2008.10.007%26rft_id%253Dinfo%253Apmid%252F19027147%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.jaci.2008.10.007&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=19027147&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000262793900015&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.24" data-doi="10.1002/jmv.20689"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Arden</span>,  <span class="cit-name-given-names">K. E.</span></span>, <span class="cit-auth"><span class="cit-name-surname">McErlean</span>,  <span class="cit-name-given-names">P.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Nissen</span>,  <span class="cit-name-given-names">M. D.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sloots</span>,  <span class="cit-name-given-names">T. P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Mackay</span>,  <span class="cit-name-given-names">I. M.</span></span> <span class="cit-article-title">Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections</span>. <abbr class="cit-jnl-abbrev">J Med Virol</abbr> <span class="cit-vol">78</span>, <span class="cit-fpage">1232</span>–<span class="cit-lpage">1240</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1002/jmv.20689</span> (<span class="cit-pub-date">2006</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bmedical%2Bvirology%26rft.stitle%253DJ%2BMed%2BVirol%26rft.aulast%253DArden%26rft.auinit1%253DK.%2BE.%26rft.volume%253D78%26rft.issue%253D9%26rft.spage%253D1232%26rft.epage%253D1240%26rft.atitle%253DFrequent%2Bdetection%2Bof%2Bhuman%2Brhinoviruses%252C%2Bparamyxoviruses%252C%2Bcoronaviruses%252C%2Band%2Bbocavirus%2Bduring%2Bacute%2Brespiratory%2Btract%2Binfections.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fjmv.20689%26rft_id%253Dinfo%253Apmid%252F16847968%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/jmv.20689&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=16847968&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">25.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.25" data-doi="10.1086/520816"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kistler</span>,  <span class="cit-name-given-names">A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Pan-viral screening of respiratory tract infections in adults with and without asthma reveals unexpected human coronavirus and human rhinovirus diversity</span>. <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-vol">196</span>, <span class="cit-fpage">817</span>–<span class="cit-lpage">825</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1086/520816</span> (<span class="cit-pub-date">2007</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F520816%26rft_id%253Dinfo%253Apmid%252F17703411%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/520816&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=17703411&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000249251800004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">26.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.26" data-doi="10.1086/508551"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Lamson</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005</span>. <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-vol">194</span>, <span class="cit-fpage">1398</span>–<span class="cit-lpage">1402</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1086/508551</span> (<span class="cit-pub-date">2006</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F508551%26rft_id%253Dinfo%253Apmid%252F17054069%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/508551&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=17054069&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000241820500008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text" id="ref-27">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.27" data-doi="10.1086/524312"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Renwick</span>,  <span class="cit-name-given-names">N.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany</span>. <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-vol">196</span>, <span class="cit-fpage">1754</span>–<span class="cit-lpage">1760</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1086/524312</span> (<span class="cit-pub-date">2007</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1086%252F524312%26rft_id%253Dinfo%253Apmid%252F18190255%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/524312&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=18190255&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000251922600008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text" id="ref-28">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.28" data-doi="10.1038/nm.2358"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bochkov</span>,  <span class="cit-name-given-names">Y. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C</span>. <abbr class="cit-jnl-abbrev">Nat Med</abbr> <span class="cit-vol">17</span>, <span class="cit-fpage">627</span>–<span class="cit-lpage">632</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1038/nm.2358</span> (<span class="cit-pub-date">2011</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bmedicine%26rft.stitle%253DNat%2BMed%26rft.aulast%253DBochkov%26rft.auinit1%253DY.%2BA.%26rft.volume%253D17%26rft.issue%253D5%26rft.spage%253D627%26rft.epage%253D632%26rft.atitle%253DMolecular%2Bmodeling%252C%2Borgan%2Bculture%2Band%2Breverse%2Bgenetics%2Bfor%2Ba%2Bnewly%2Bidentified%2Bhuman%2Brhinovirus%2BC.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnm.2358%26rft_id%253Dinfo%253Apmid%252F21483405%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nm.2358&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=21483405&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text" id="ref-29">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.29" data-doi="10.1073/pnas.1421178112"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bochkov</span>,  <span class="cit-name-given-names">Y. A.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-vol">112</span>, <span class="cit-fpage">5485</span>–<span class="cit-lpage">5490</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1073/pnas.1421178112</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BU%2BS%2BA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.1421178112%26rft_id%253Dinfo%253Apmid%252F25848009%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiMTEyLzE3LzU0ODUiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNi8wNS8xNy8wNTM5NjcuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text" id="ref-30">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.30" data-doi="10.1038/nm1713"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Bartlett</span>,  <span class="cit-name-given-names">N. W.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation</span>. <abbr class="cit-jnl-abbrev">Nature medicine</abbr> <span class="cit-vol">14</span>, <span class="cit-fpage">199</span>–<span class="cit-lpage">204</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1038/nm1713</span> (<span class="cit-pub-date">2008</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bmedicine%26rft.stitle%253DNat%2BMed%26rft.aulast%253DBartlett%26rft.auinit1%253DN.%2BW.%26rft.volume%253D14%26rft.issue%253D2%26rft.spage%253D199%26rft.epage%253D204%26rft.atitle%253DMouse%2Bmodels%2Bof%2Brhinovirus-induced%2Bdisease%2Band%2Bexacerbation%2Bof%2Ballergic%2Bairway%2Binflammation.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnm1713%26rft_id%253Dinfo%253Apmid%252F18246079%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nm1713&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=18246079&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000252946700030&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text" id="ref-31">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.31" data-doi="10.1016/j.trivac.2014.02.003"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Blanco</span>,  <span class="cit-name-given-names">J. C.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Prophylactic Antibody Treatment and Intramuscular Immunization Reduce Infectious Human Rhinovirus 16 Load in the Lower Respiratory Tract of Challenged Cotton Rats</span>. <abbr class="cit-jnl-abbrev">Trials Vaccinol</abbr> <span class="cit-vol">3</span>, <span class="cit-fpage">52</span>–<span class="cit-lpage">60</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1016/j.trivac.2014.02.003</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DTrials%2BVaccinol%26rft.volume%253D3%26rft.spage%253D52%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.trivac.2014.02.003%26rft_id%253Dinfo%253Apmid%252F25328560%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/j.trivac.2014.02.003&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=25328560&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text" id="ref-32">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.32" data-doi="10.1073/pnas.0912458109"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kim</span>,  <span class="cit-name-given-names">J. H.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Davis</span>,  <span class="cit-name-given-names">W. G.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Sambhara</span>,  <span class="cit-name-given-names">S.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Jacob</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-article-title">Strategies to alleviate original antigenic sin responses to influenza viruses</span>. <abbr class="cit-jnl-abbrev">Proc Natl Acad Sci U S A</abbr> <span class="cit-vol">109</span>, <span class="cit-fpage">13751</span>–<span class="cit-lpage">13756</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1073/pnas.0912458109</span> (<span class="cit-pub-date">2012</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc%2BNatl%2BAcad%2BSci%2BU%2BS%2BA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.0912458109%26rft_id%253Dinfo%253Apmid%252F22869731%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMjoiMTA5LzM0LzEzNzUxIjtzOjQ6ImF0b20iO3M6Mzc6Ii9iaW9yeGl2L2Vhcmx5LzIwMTYvMDUvMTcvMDUzOTY3LmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">33.</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33. in text" id="ref-33">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.33" data-doi="10.1093/infdis/132.6.623"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Hamory</span>,  <span class="cit-name-given-names">B. H.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Hamparian</span>,  <span class="cit-name-given-names">V. V.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Conant</span>,  <span class="cit-name-given-names">R. M.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Gwaltney</span>,  <span class="cit-name-given-names">J. M.</span>,   <span class="cit-name-suffix">Jr.</span>.</span> <span class="cit-article-title">Human responses to two decavalent rhinovirus vaccines</span>. <abbr class="cit-jnl-abbrev">J Infect Dis</abbr> <span class="cit-vol">132</span>, <span class="cit-fpage">623</span>–<span class="cit-lpage">629</span> (<span class="cit-pub-date">1975</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ%2BInfect%2BDis%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F132.6.623%26rft_id%253Dinfo%253Apmid%252F172561%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/132.6.623&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=172561&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">34.</span><a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference 34. in text" id="ref-34">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.34" data-doi="10.1126/science.6272391"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Racaniello</span>,  <span class="cit-name-given-names">V. R.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Baltimore</span>,  <span class="cit-name-given-names">D.</span></span> <span class="cit-article-title">Cloned poliovirus complementary DNA is infectious in mammalian cells</span>. <abbr class="cit-jnl-abbrev">Science</abbr> <span class="cit-vol">214</span>, <span class="cit-fpage">916</span>–<span class="cit-lpage">919</span> (<span class="cit-pub-date">1981</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DScience%26rft.stitle%253DScience%26rft.aulast%253DRacaniello%26rft.auinit1%253DV.%26rft.volume%253D214%26rft.issue%253D4523%26rft.spage%253D916%26rft.epage%253D919%26rft.atitle%253DCloned%2Bpoliovirus%2Bcomplementary%2BDNA%2Bis%2Binfectious%2Bin%2Bmammalian%2Bcells%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fscience.6272391%26rft_id%253Dinfo%253Apmid%252F6272391%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6Mzoic2NpIjtzOjU6InJlc2lkIjtzOjEyOiIyMTQvNDUyMy85MTYiO3M6NDoiYXRvbSI7czozNzoiL2Jpb3J4aXYvZWFybHkvMjAxNi8wNS8xNy8wNTM5NjcuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">35.</span><a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference 35. in text" id="ref-35">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.35" data-doi="10.1021/bp049692b"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Farid</span>,  <span class="cit-name-given-names">S. S.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Washbrook</span>,  <span class="cit-name-given-names">J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Titchener-Hooker</span>,  <span class="cit-name-given-names">N. J.</span></span> <span class="cit-article-title">Decision-support tool for assessing biomanufacturing strategies under uncertainty: stainless steel versus disposable equipment for clinical trial material preparation</span>. <abbr class="cit-jnl-abbrev">Biotechnol Prog</abbr> <span class="cit-vol">21</span>, <span class="cit-fpage">486</span>–<span class="cit-lpage">497</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1021/bp049692b</span> (<span class="cit-pub-date">2005</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBiotechnology%2BProgress%2B%2528Print%2529%26rft.stitle%253DBiotechnology%2BProgress%2B%2528Print%2529%26rft.aulast%253DFarid%26rft.auinit1%253DS.%2BS.%26rft.volume%253D21%26rft.issue%253D2%26rft.spage%253D486%26rft.epage%253D497%26rft.atitle%253DDecision-support%2Btool%2Bfor%2Bassessing%2Bbiomanufacturing%2Bstrategies%2Bunder%2Buncertainty%253A%2Bstainless%2Bsteel%2Bversus%2Bdisposable%2Bequipment%2Bfor%2Bclinical%2Btrial%2Bmaterial%2Bpreparation.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fbp049692b%26rft_id%253Dinfo%253Apmid%252F15801789%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/bp049692b&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=15801789&amp;link_type=MED&amp;atom=%2Fbiorxiv%2Fearly%2F2016%2F05%2F17%2F053967.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">36.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.36" data-doi="10.1371/journal.pone.0083374"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Thomassen</span>,  <span class="cit-name-given-names">Y. E.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals</span>. <abbr class="cit-jnl-abbrev">PLoS One</abbr> <span class="cit-vol">8</span>, <span class="cit-fpage">e83374</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1371/journal.pone.0083374</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DPLoS%2BOne%26rft.volume%253D8%26rft.spage%253De83374%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0083374%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1371/journal.pone.0083374&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">37.</span><a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference 37. in text" id="ref-37">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.37" data-doi="10.1002/bit.24798"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Thomassen</span>,  <span class="cit-name-given-names">Y. E.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Scale-down of the inactivated polio vaccine production process</span>. <abbr class="cit-jnl-abbrev">BiotechnolBioeng</abbr> <span class="cit-vol">110</span>, <span class="cit-fpage">1354</span>–<span class="cit-lpage">1365</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1002/bit.24798</span> (<span class="cit-pub-date">2013</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DBiotechnolBioeng%26rft.volume%253D110%26rft.spage%253D1354%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fbit.24798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/bit.24798&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">38.</span><a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference 38. in text" id="ref-38">↵</a><div class="cit ref-cit ref-journal" id="cit-053967v1.38" data-doi="10.1002/prot.22879"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Reed</span>,  <span class="cit-name-given-names">L. J.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Muench</span>,  <span class="cit-name-given-names">H.</span></span> <span class="cit-article-title">A simple method of estimating fifty per cent endpoints</span>. <abbr class="cit-jnl-abbrev">Am J Hyg</abbr> <span class="cit-vol">27</span>, <span class="cit-fpage">493</span>–<span class="cit-lpage">497</span> (<span class="cit-pub-date">1938</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAm%2BJ%2BHyg%26rft.volume%253D27%26rft.spage%253D493%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fprot.22879%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1002/prot.22879&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">39.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.39" data-doi="10.1186/1743-422X-11-99"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Kattur Venkatachalam</span>,  <span class="cit-name-given-names">A. R.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Szyporta</span>,  <span class="cit-name-given-names">M.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Kiener</span>,  <span class="cit-name-given-names">T. K.</span></span>, <span class="cit-auth"><span class="cit-name-surname">Balraj</span>,  <span class="cit-name-given-names">P.</span></span> &amp; <span class="cit-auth"><span class="cit-name-surname">Kwang</span>,  <span class="cit-name-given-names">J.</span></span> <span class="cit-article-title">Concentration and purification of enterovirus 71 using a weak anion-exchange monolithic column</span>. <abbr class="cit-jnl-abbrev">Virol J</abbr> <span class="cit-vol">11</span>, <span class="cit-fpage">99</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1186/1743-422X-11-99</span> (<span class="cit-pub-date">2014</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DVirol%2BJ%26rft.volume%253D11%26rft.spage%253D99%26rft_id%253Dinfo%253Adoi%252F10.1186%252F1743-422X-11-99%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1186/1743-422X-11-99&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li><li><span class="ref-label">40.</span><div class="cit ref-cit ref-journal no-rev-xref" id="cit-053967v1.40" data-doi="10.1007/978-1-4939-1571-2_9"><div class="cit-metadata"><cite><span class="cit-auth"><span class="cit-name-surname">Weiss</span>,  <span class="cit-name-given-names">V. U.</span></span> <span class="cit-etal">et al.</span> <span class="cit-article-title">Capillary electrophoresis, gas-phase electrophoretic mobility molecular analysis, and electron microscopy: effective tools for quality assessment and basic rhinovirus research</span>. <abbr class="cit-jnl-abbrev">Methods MolBiol</abbr> <span class="cit-vol">1221</span>, <span class="cit-fpage">101</span>–<span class="cit-lpage">128</span><span class="cit-pub-id-sep cit-pub-id-doi-sep">, </span><span class="cit-pub-id-scheme">doi:</span><span class="cit-pub-id cit-pub-id-doi">10.1007/978-1-4939-1571-2_9</span> (<span class="cit-pub-date">2015</span>).</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DMethods%2BMolBiol%26rft.volume%253D1221%26rft.spage%253D101%26rft_id%253Dinfo%253Adoi%252F10.1007%252F978-1-4939-1571-2_9%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1007/978-1-4939-1571-2_9&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://www.biorxiv.org/content/10.1101/053967v1.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-disqus-comment" >
  
      
  
  <div class="pane-content">
    <div id="disqus_thread"><noscript><p><a href="http://biorxivstage.disqus.com/?url=https%3A%2F%2Fwww.biorxiv.org%2Fcontent%2F10.1101%2F053967v1" class="" data-icon-position="" data-hide-link-title="0">View the discussion thread.</a></p></noscript></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/10.1101/053868v1" title="EGAD: Ultra-fast functional analysis of gene networks" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/10.1101/053678v1" title="A hyperactive transcriptional state marks genome reactivation at the mitosis-G1 transition" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1" >
  
      
  
  <div class="pane-content">
    Posted&nbsp;May 17, 2016.  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-art-tools" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/10.1101/053967v1.full.pdf" target="_self" class="article-dl-pdf-link link-icon"><i class="icon-external-link-sign"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-biorxiv-supplementary-fragment" >
  
      
  
  <div class="pane-content">
    <p><a href="/content/10.1101/053967v1.supplementary-material"><i class="icon-file"></i>Supplementary Material </a></p>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/10.1101/053967v1.full" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for your interest in spreading the word about bioRxiv.</p><p>NOTE: Your email address is requested solely to identify you as the sender of this article.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/10.1101/053967v1" class="active" data-icon-position="" data-hide-link-title="0">50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from bioRxiv
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would like to see this page from the bioRxiv website.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/14772" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-dZu8y0cv44PdI_Xev3_5ZLLcidnTY1w-QmCeXzb1La8" />
<input type="hidden" name="form_id" value="forward_form" />
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="14772" id="node14772--2" data-pisa="biorxiv;053967v1" data-pisa-master="biorxiv;053967" data-seqnum="14772" data-apath="/biorxiv/early/2016/05/17/053967.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Sujin</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Minh Trang</span> <span class="nlm-surname">Nguyen</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Michael G.</span> <span class="nlm-surname">Currier</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Joe B.</span> <span class="nlm-surname">Jenkins</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Elizabeth A.</span> <span class="nlm-surname">Strobert</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Adriana E.</span> <span class="nlm-surname">Kajon</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ranjna</span> <span class="nlm-surname">Madan-Lala</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yury A.</span> <span class="nlm-surname">Bochkov</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">James E.</span> <span class="nlm-surname">Gern</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Krishnendu</span> <span class="nlm-surname">Roy</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Xiaoyan</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="11"><span class="nlm-given-names">Dean D.</span> <span class="nlm-surname">Erdman</span></span>, <span class="highwire-citation-author" data-delta="12"><span class="nlm-given-names">Paul</span> <span class="nlm-surname">Spearman</span></span>, <span class="highwire-citation-author" data-delta="13"><span class="nlm-given-names">Martin L.</span> <span class="nlm-surname">Moore</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">053967; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/053967 </span></div>
  
  
  </div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://www.biorxiv.org/content/10.1101/053967v1" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://digg.com/submit?phase=2&amp;url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;title=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;title=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;text=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;title=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;t=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;title=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;title=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0"><img src="https://www.biorxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools"><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="14772" id="node14772--3" data-pisa="biorxiv;053967v1" data-pisa-master="biorxiv;053967" data-seqnum="14772" data-apath="/biorxiv/early/2016/05/17/053967.atom"><div  class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix" >

      <div class="highwire-cite-title" >
      <div class="highwire-cite-title">50-valent inactivated rhinovirus vaccine is broadly immunogenic in rhesus macaques</div>    </div>
  
      <div  class="highwire-cite-authors" ><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Sujin</span> <span class="nlm-surname">Lee</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">Minh Trang</span> <span class="nlm-surname">Nguyen</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Michael G.</span> <span class="nlm-surname">Currier</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Joe B.</span> <span class="nlm-surname">Jenkins</span></span>, <span class="highwire-citation-author" data-delta="4"><span class="nlm-given-names">Elizabeth A.</span> <span class="nlm-surname">Strobert</span></span>, <span class="highwire-citation-author" data-delta="5"><span class="nlm-given-names">Adriana E.</span> <span class="nlm-surname">Kajon</span></span>, <span class="highwire-citation-author" data-delta="6"><span class="nlm-given-names">Ranjna</span> <span class="nlm-surname">Madan-Lala</span></span>, <span class="highwire-citation-author" data-delta="7"><span class="nlm-given-names">Yury A.</span> <span class="nlm-surname">Bochkov</span></span>, <span class="highwire-citation-author" data-delta="8"><span class="nlm-given-names">James E.</span> <span class="nlm-surname">Gern</span></span>, <span class="highwire-citation-author" data-delta="9"><span class="nlm-given-names">Krishnendu</span> <span class="nlm-surname">Roy</span></span>, <span class="highwire-citation-author" data-delta="10"><span class="nlm-given-names">Xiaoyan</span> <span class="nlm-surname">Lu</span></span>, <span class="highwire-citation-author" data-delta="11"><span class="nlm-given-names">Dean D.</span> <span class="nlm-surname">Erdman</span></span>, <span class="highwire-citation-author" data-delta="12"><span class="nlm-given-names">Paul</span> <span class="nlm-surname">Spearman</span></span>, <span class="highwire-citation-author" data-delta="13"><span class="nlm-given-names">Martin L.</span> <span class="nlm-surname">Moore</span></span></span></div>
  
      <div  class="highwire-cite-metadata" ><span  class="highwire-cite-metadata-journal highwire-cite-metadata">bioRxiv </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">053967; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="doi_label">doi:</span> https://doi.org/10.1101/053967 </span></div>
  
  
  </div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage&amp;rft.epage&amp;rft.atitle=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques&amp;rft.volume&amp;rft.issue&amp;rft.date=2016-01-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=bioRxiv&amp;rft.au=Lee%2C+Sujin&amp;rft.au=Nguyen%2C+Minh+Trang&amp;rft.au=Currier%2C+Michael+G.&amp;rft.au=Jenkins%2C+Joe+B.&amp;rft.au=Strobert%2C+Elizabeth+A.&amp;rft.au=Kajon%2C+Adriana+E.&amp;rft.au=Madan-Lala%2C+Ranjna&amp;rft.au=Bochkov%2C+Yury+A.&amp;rft.au=Gern%2C+James+E.&amp;rft.au=Roy%2C+Krishnendu&amp;rft.au=Lu%2C+Xiaoyan&amp;rft.au=Erdman%2C+Dean+D.&amp;rft.au=Spearman%2C+Paul&amp;rft.au=Moore%2C+Martin+L."></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/14772/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/14772/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/14772/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/14772/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/14772/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/14772/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/14772/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/14772/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/14772/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/14772/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/14772/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/14772/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><div class="item-list"><ul><li class="first"><a href="http://twitter.com/share?url=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;count=horizontal&amp;via=&amp;text=50-valent%20inactivated%20rhinovirus%20vaccine%20is%20broadly%20immunogenic%20in%20rhesus%20macaques&amp;counturl=https%3A//www.biorxiv.org/content/10.1101/053967v1" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Tweet Widget</span></a></li><li><a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.biorxiv.org/content/10.1101/053967v1&amp;layout=button_count&amp;show_faces=false&amp;action=like&amp;colorscheme=light&amp;width=100&amp;height=21&amp;font=&amp;locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Facebook Like</span></a></li><li class="last"><a href="https://www.biorxiv.org/content/10.1101/053967v1" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0"><span class="element-invisible">Google Plus One</span></a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-collections" >
  
        <h2 class="pane-title">Subject Area</h2>
    
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-collections"><div class="highwire-list"><ul class="highwire-article-collection-term-list"><li class="first last odd"><span class="highwire-article-collection-term"><a href="/collection/immunology" class="highlight" data-icon-position="" data-hide-link-title="0">Immunology<i class="icon-caret-right"></i>
</a></span></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2" >
  
      
  
  <div class="pane-content">
    <div class="panel-flexible panels-flexible-8 clearfix" id="mini-panel-biorxiv_subject_collections">
<div class="panel-flexible-inside panels-flexible-8-inside">
<div class="panels-flexible-region panels-flexible-region-8-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-8-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
  
      
  <div class="snippet-content">
    <b>Subject Areas</b>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-snippet" >
  
      
  
  <div class="pane-content">
    <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
  
      
  <div class="snippet-content">
    <a href="/content/early/recent"><strong>All Articles</strong></a>  </div>

</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-subject-collections" >
  
      
  
  <div class="pane-content">
    <ul id="collection" class="collection highwire-list-expand"><li class="outer collection depth-2  child first"><div class = "data-wrapper"><a href="/collection/animal-behavior-and-cognition" class="" data-icon-position="" data-hide-link-title="0">Animal Behavior and Cognition</a> <span class = "article-count">(1789)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biochemistry" class="" data-icon-position="" data-hide-link-title="0">Biochemistry</a> <span class = "article-count">(3141)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioengineering" class="" data-icon-position="" data-hide-link-title="0">Bioengineering</a> <span class = "article-count">(2136)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/bioinformatics" class="" data-icon-position="" data-hide-link-title="0">Bioinformatics</a> <span class = "article-count">(11098)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/biophysics" class="" data-icon-position="" data-hide-link-title="0">Biophysics</a> <span class = "article-count">(4575)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cancer-biology" class="" data-icon-position="" data-hide-link-title="0">Cancer Biology</a> <span class = "article-count">(3584)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/cell-biology" class="" data-icon-position="" data-hide-link-title="0">Cell Biology</a> <span class = "article-count">(5072)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/clinical-trials" class="" data-icon-position="" data-hide-link-title="0">Clinical Trials</a> <span class = "article-count">(137)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/developmental-biology" class="" data-icon-position="" data-hide-link-title="0">Developmental Biology</a> <span class = "article-count">(3114)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/ecology" class="" data-icon-position="" data-hide-link-title="0">Ecology</a> <span class = "article-count">(4915)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">Epidemiology</a> <span class = "article-count">(2044)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/evolutionary-biology" class="" data-icon-position="" data-hide-link-title="0">Evolutionary Biology</a> <span class = "article-count">(7708)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genetics" class="" data-icon-position="" data-hide-link-title="0">Genetics</a> <span class = "article-count">(5844)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/genomics" class="" data-icon-position="" data-hide-link-title="0">Genomics</a> <span class = "article-count">(7321)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/immunology" class="" data-icon-position="" data-hide-link-title="0">Immunology</a> <span class = "article-count">(2735)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/microbiology" class="" data-icon-position="" data-hide-link-title="0">Microbiology</a> <span class = "article-count">(8398)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/molecular-biology" class="" data-icon-position="" data-hide-link-title="0">Molecular Biology</a> <span class = "article-count">(3345)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/neuroscience" class="" data-icon-position="" data-hide-link-title="0">Neuroscience</a> <span class = "article-count">(20277)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/paleontology" class="" data-icon-position="" data-hide-link-title="0">Paleontology</a> <span class = "article-count">(147)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">Pathology</a> <span class = "article-count">(529)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/pharmacology-and-toxicology" class="" data-icon-position="" data-hide-link-title="0">Pharmacology and Toxicology</a> <span class = "article-count">(867)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/physiology" class="" data-icon-position="" data-hide-link-title="0">Physiology</a> <span class = "article-count">(1311)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/plant-biology" class="" data-icon-position="" data-hide-link-title="0">Plant Biology</a> <span class = "article-count">(3026)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/scientific-communication-and-education" class="" data-icon-position="" data-hide-link-title="0">Scientific Communication and Education</a> <span class = "article-count">(736)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/synthetic-biology" class="" data-icon-position="" data-hide-link-title="0">Synthetic Biology</a> <span class = "article-count">(976)</span></div></li>
<li class="outer collection depth-2  child"><div class = "data-wrapper"><a href="/collection/systems-biology" class="" data-icon-position="" data-hide-link-title="0">Systems Biology</a> <span class = "article-count">(3039)</span></div></li>
<li class="outer collection depth-2  child last"><div class = "data-wrapper"><a href="/collection/zoology" class="" data-icon-position="" data-hide-link-title="0">Zoology</a> <span class = "article-count">(503)</span></div></li>
</ul>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js" defer="defer"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__llgGUcz2-k3Jmyyyog-_4yI1wJfGWwx0eQ2lbnM9IIo__t6UjIjIKIAD6nKc6BAU9qmlVV2VR4CBTNQbxlbJPgN0__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" src="//d33xdlntwy0kbs.cloudfront.net/cshl_custom.js"></script>
<script type="text/javascript" src="https://www.biorxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__qVkFI2DFUJCJKlH2laKecaY5NNjWWYhnp4WnclrNmRk.js"></script>
  </body>
</html>
